fibrinogen has been researched along with Cirrhosis, Liver in 256 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 166 (64.84) | 18.7374 |
1990's | 23 (8.98) | 18.2507 |
2000's | 20 (7.81) | 29.6817 |
2010's | 33 (12.89) | 24.3611 |
2020's | 14 (5.47) | 2.80 |
Authors | Studies |
---|---|
Adelmeijer, J; Bernal, W; Blasi, A; de Haas, RJ; Driever, EG; Fondevila, C; Gregory, S; Heaton, N; Kane, P; Lisman, T; Nagasami, C; Porte, RJ; van den Heuvel, MC; von Meijenfeldt, FA; Weisel, JW; Zen, Y | 1 |
Adelmeijer, J; Bernal, W; Blasi, A; Calvo, A; Corcoran, E; Fernandez, J; Lisman, T; Patel, VC; Spanke, ENHE; Stamouli, M; Zamalloa, A | 1 |
Enein, AA; Hussein, E | 1 |
Doyle, MB; Drobish, J; Jarasvaraparn, C; Khan, A; Kulkarni, S; Nadler, M; Rusch, C; Stoll, J | 1 |
Hidaka, H; Horie, R; Kubo, M; Kusano, C; Kuwana, M; Miyazaki, K; Satoh, T; Takiguchi, H; Tanaka, C; Uojima, H; Wada, N; Yokoyama, F | 1 |
Cai, X; Chen, J; Li, H; Tang, D; Zhang, P | 1 |
Han, M; Huang, J; Luo, X; Ning, Q; Tao, R; Wan, X; Wang, X; Xiao, F; Yan, W; Yuan, W | 1 |
Arévalo, AG; Blasi, A; Cendrós, JM; Colom, H; Montoro, B; Sabaté, A | 1 |
Adelmeijer, J; Bernal, W; Driever, EG; Koenderink, GH; Lisman, T; Muntz, I; Patel, V | 1 |
He, X; Li, Y; Pang, H | 1 |
Han, NK; Han, SC; Jeong, YJ; Jung, MG; Kim, SH; Lee, HJ; Lee, YJ; Lim, YB; Park, S; Park, SC; Son, Y | 1 |
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
Alsobrooks, JP; Budnick, IM; Davis, JPE; Intagliata, NM; Konkol, SB; Lau, CE; Lisman, T; Northup, PG; Stotts, MJ; Sundararaghavan, A | 1 |
Balsano, C; Capone, D; Citro, V; Gaudiano, G; Santini, SJ; Sinatti, G; Tarantino, G | 1 |
Jou, J; McMurry, HS; Shatzel, J | 1 |
Araj, E; De Simone, N; Laknezhad, S; Sarode, R; Usmani, A | 1 |
Govitrapong, P; Isarankura-Na-Ayudhya, C; Kitidee, K; Klosen, P; Pannengpetch, S; Wongchitrat, P | 1 |
Goya, T; Kato, M; Kohjima, M; Mutsuki, T; Ohe, M; Satoh, T; Yamashita, S | 1 |
Alnor, AB; Hvas, AM; Nybo, M; Vinholt, PJ | 1 |
Gong, Z; Yan, C; Yang, Q | 1 |
Bodini, G; Brunacci, M; Furnari, M; Giambruno, E; Giannini, EG; Plaz Torres, MC; Savarino, V; Zentilin, P | 1 |
Abdel Moneim, AE; Abdelhabib, S; Almeer, RS; El-Khadragy, MF | 1 |
Ibanez, IG; Klaus, F; Lohse, A; Meyer, B; Nagel, T; Wege, H | 1 |
Binh, MT; Hoan, NX; Meyer, CG; Quyen, DT; Quyet, D; Son, HA; Song, LH; Toan, NL; Van Ba, N; Van Luong, H; Van Tong, H; Velavan, TP | 1 |
Kurabekova, RM; Shevchenko, OP; Tsirulnikova, OM | 1 |
Bonnet, N; Clapuyt, P; Detaille, T; Dumitriu, D; Eeckhoudt, S; Helleputte, T; Hermans, C; Menten, R; Paul, J; Pirotte, T; Prégardien, C; Reding, R; Scheers, I; Smets, F; Sokal, E; Stéphenne, X; Varma, S; Veyckemans, F | 1 |
Biancofiore, G; Blasi, A; De Boer, MT; Franchini, M; Hartmann, M; Lisman, T; Liumbruno, GM; Porte, RJ; Saner, F; Senzolo, M; Werner, MJ | 1 |
Li, P; Li, Z; Lu, Y; Sun, D; Xu, Y; Zhang, X | 1 |
Caldwell, SH; Greenberg, CS; O'Leary, JG; Patton, HM | 1 |
Joshi, N; Kopec, AK; Luyendyk, JP; Towery, K; Williams, KJ | 1 |
Casals, G; Crespo, G; Forns, X; Jiménez, W; Marfà, S; Morales-Ruiz, M; Navasa, M; Reichenbach, V | 1 |
Chmura, A; Kosieradzki, M; Lągiewska, B; Lazowski, T; Nicińska, B; Pluta, J; Trzebicki, J; Wasiak, D | 1 |
Akyol, G; Callea, F; Dalgic, B; Francalanci, P; Giovannoni, I; Gonul, II; Sari, S; Yilmaz, G | 1 |
Chernousov, AF; Karpova, RV; Khorobrykh, TV | 1 |
de Ridder, GG; Lundblad, RL; Pizzo, SV | 1 |
Chen, J; Dong, J; Jiang, J; Lin, S; Shao, L; Wang, M; Weng, Z; Zhu, Y | 1 |
Chmura, A; Kołacz, M; Lisik, W; Nicińska, B; Pluta, J; Trzebicki, J; Łągiewska, B | 1 |
Liang, J; Song, W; Yang, C; Zhang, M; Zhao, Y; Zheng, W; Zheng, Y | 1 |
Ariëns, RA; Lisman, T | 1 |
Desborough, MJ; Jairath, V; Kahan, BC; Stanworth, SJ | 1 |
Gao, H; Jiang, L; Liu, C; Qin, R; Wang, M; Xiao, G; Yan, L; Yang, J; Ye, D; Zhang, H; Zhu, F | 1 |
Dai, M; Guan, WB; Ke, QS; Li, YM; Xie, HP; Yang, HZ; Zhang, SJ | 1 |
Janssen, HL; Jie, KS; Leebeek, FW; Pattynama, PM; Smalberg, JH; Spaander, MV; van Buuren, HR; van den Berg, B | 1 |
Bridle, KR; Clouston, AD; Crawford, DH; Fletcher, LM; Morgan, ML; Popa, C; Sobbe, AL | 1 |
Ha, KS; Jung, SH; Kim, YM; Kong, DH; Kwon, MH; Suh, IB | 1 |
Allen, K; Cantor, GH; Copple, BL; Guo, GL; Kassel, KM; Li, G; Luyendyk, JP | 1 |
Brzacki, V; Dinic-Radovic, V; Nagorni, A; Radovic, M; Ristic, L | 1 |
Gornjakovic, S; Mesihovic, R; Prohic, D; Saray, A; Vanis, N | 1 |
Abdo, AA; Gader, AG; Saja, MF; Sanai, FM; Shaikh, SA | 1 |
Imazeki, F; Kanai, F; Kuga, T; Nakajima, A; Nishimura, M; Noda, K; Nomura, F; Seimiya, M; Sogawa, K; Takizawa, H; Tomonaga, T; Tsutsumi, M; Umemura, H; Yokosuka, O; Yoneda, M | 1 |
Ghalib, R; Goss, J; Hassan, M; Levine, C; McClelland, T; Patt, YZ; Seu, P; Stribling, R | 1 |
BARBAGALLO-SANGIORGI, G; CAPUTO, A | 1 |
RETTENBACHER, F; SCHNEIDERBAUR, A | 1 |
MASETTO, I | 1 |
BELOVA, IV | 1 |
AUDITORE, JV; ENDE, N | 1 |
BAESSLER, KH; PRELLWITZ, W | 1 |
HALLEN, A; NILSSON, IM | 1 |
SAMAMA, M | 1 |
CROMWELL, S; MCFARLANE, AS; TODD, D | 1 |
AMRIS, A; AMRIS, CJ | 1 |
ALKJAERSIG, N; FLETCHER, AP; SHERRY, S | 1 |
SHARP, AA | 1 |
Anwar, MA; Rampling, MW | 1 |
Friedman, SL | 1 |
Bai, J; Cong, YL; Wei, YX; Yin, ZJ; Zhang, LW | 1 |
Bridle, K; Chang, P; Hung, DY; Roberts, MS; Siebert, GA | 1 |
Dhillon, AP; Difford, J; Etessami, N; Quaglia, A; Sim, R | 1 |
Başkol, M; Eser, B; Gürsoy, S; Güven, K; Ozbakir, O; Soyuer, I; Torun, E; Yücesoy, M; Yurci, A | 1 |
Akyol, G; Cindoruk, M; Degertekin, B; Ekinci, O; Karakan, T; Simsek, Z; Unal, S | 1 |
Göksel, V; Karaca, M; Yavuzgil, C | 1 |
Malé, PJ; Neerman-Arbez, M; Rougemont, AL; Rubbia-Brandt, L; Spahr, L | 1 |
Green, K; Mann, DA; Mann, J; Millward-Sadler, H; Oakley, F; Reynolds, G; Smart, DE; Weitzman, JB; Yaniv, M | 1 |
Ademoglu, E; Cefle, K; Gokkusu, C; Guler, K; Ozturk, S; Palanduz, S; Tamer, S; Vatansever, S | 1 |
Neerman-Arbez, M | 1 |
Knight, B; Lim, R; Olynyk, JK; Yeoh, GC | 1 |
Czakó, T; Papp, Z | 1 |
Cappellato, G; Dal Bo Zanon, R; Farinati, F; Girolami, A; Levi Minzi, S; Pengo, V | 1 |
Itakura, M; Iwamura, K; Kamiguchi, H; Katsunuma, T; Matsuzaki, S | 1 |
Neidhardt, B; Schricker, KT | 1 |
Drobnik, S; Dworniak, D; Tkacz, B | 1 |
Genth, K; Heene, DL | 1 |
Armstrong, DJ; Francis, JL | 1 |
Bernardi, M; Brocchi, E; Caletti, GC; Gasbarrini, G; Palareti, G; Pini, P | 1 |
Gollwitzer, R; Graeff, H; Hafter, R; Klaubert, E; Klaubert, W; von Hugo, R | 1 |
Alessandri, C; Balsano, F; Cordova, C; Ferro, D; Musca, A; Piromalli, A; Violi, F | 1 |
Comp, PC; Jacocks, RM; Radcliffe, R; Rubenstein, C | 1 |
Dudley, FJ; Gibson, PR; Jakobovits, AW; McInnes, IE; Salem, HH | 1 |
Hidai, K; Kamisasa, I; Sugiura, M; Wada, T; Yamanaka, M | 1 |
Harker, LA; Stein, SF | 1 |
Boyle, JM; Goodnough, LT; Heimburger, N; Saito, H | 1 |
Schipper, HG; ten Cate, JW | 1 |
Coccheri, S; Gervasoni, W; Mannucci, PM; Palareti, G; Poggi, M; Viganò, S | 1 |
Cuesta, B; Febres, R; Fernández, J; López Fernández, A; Narvaiza, MJ; Páramo, JA; Rocha, E | 1 |
Cristea, A; Cucuianu, MP; Missits, I; Roman, S | 1 |
Labastida-Muñoz, H; Landero de Ruiz, N; Ruiz-Argüelles, GJ; Ruiz-Reyes, G; Sánchez-Fernández, M | 1 |
Avventi, GL; Bonadiman, L; Doni, MG; Meduri, F; Vassanelli, P | 1 |
Egbring, R; Havemann, K; Klingemann, HG | 1 |
Giolma, JP; Kies, MS; Posch, JJ; Rubin, RN | 1 |
Bassi, N; Burra, P; De Silvestro, G; Nolli, ML; Patrassi, GM; Piccinni, P; Rossaro, L; Sartori, MT; Viero, M | 1 |
Hughes, RD; Izumi, S; Langley, PG; Pernambuco, JR; Williams, R | 1 |
de Maat, MP; Knot, EA; Nieuwenhuizen, W; Swart, GR; van Buuren, HR | 1 |
Pósán, E; Tornai, I; Udvardy, M | 1 |
Benhamou, JP; Bernuau, J; Crusiaux, A; Devaster, JM; Devière, J; Durand, F; Goldman, M; Le Moine, O | 1 |
Alessandri, C; Andreozzi, P; Basili, S; Cordova, C; Maurelli, M; Violi, F | 1 |
Amemiya, N; Endo, T; Kume, S | 1 |
Iwamoto, N; Kambayashi, J; Kawasaki, T; Mori, T; Ou, M; Sakon, M; Shiba, E; Shinozaki, K; Uemura, Y | 1 |
Brudasca, I; Cucuianu, M; Stancu, A; Trif, I | 1 |
Bird, AR; Kahn, D; Kirsch, RE; Kruskal, J; Robson, SC | 1 |
Anderson, SE; Ballmer, PE; Garlick, PJ; McNurlan, MA; Reichen, J; Sterchi, AB | 1 |
Ishida, H; Itakura, M; Matsuzaki, S; Shiraishi, K; Watanabe, M | 1 |
Alessandri, C; Andreozzi, P; Basili, S; Cara, D; Cordova, C; Maurelli, M; Vieri, M | 1 |
Erhard, J; Kabatnik, M; Peters, J; Scherer, R | 1 |
Cindoruk, M; Doğan, UB; Dumlu, S; Unal, S; Unlü, R | 1 |
Fehr, M; Mischke, R; Nolte, I; Pöhle, D; Schoon, HA | 1 |
Ben-Ari, Z; Burroughs, AK; Hutton, RA; Osman, E | 1 |
Agarwal, S; Joyner, KA; Swaim, MW | 1 |
Brennan, SO; Callea, F; Fabbretti, G; George, PM; Kudryk, B; Medicina, D | 1 |
Gabriel, DA; Roberts, HR; Stinchcombe, TE | 1 |
Ballard, HS; Marcus, AJ | 1 |
Damus, PS; Wallace, GA | 1 |
Astedt, B; Svanberg, L | 1 |
Abildgaard, U; Lie, M; Odegard, OR | 1 |
Bugat, R; Duffaut, M; Mignon-Conte, M; Orfila, C; Rumeau, JL; Suc, JM | 1 |
Jones, CE | 1 |
Heerklotz, I; Huyke, R; Vogel, G | 1 |
Braunstein, KM; Craig, WR; Eurenius, K; Hepfer, TW; Kinard, HB | 1 |
Dymock, IW; Green, G; Poller, L; Thomson, JM | 3 |
Lechner, K; Niessner, H; Thaler, E | 1 |
Johnson, PJ; White, Y; Williams, R; Woolf, IL | 1 |
Boggian, O; Coccheri, S; Dalmonte, PR; Palareti, G; Poggi, M | 1 |
Endo, O; Fukushima, K; Ikeuchi, T; Moroi, T; Nagakura, Y; Suyama, T; Tarao, K | 1 |
Harenberg, J; Hepp, G; Schmidt-Gayk, H | 1 |
Abe, T; Kazama, M; Miura, Y; Yasuda, J | 1 |
Hofmann, V; Mombelli, G; Straub, PW | 1 |
Azzam, ZA; El-Sawy, MA; Tawfik, S; Zeina, AA | 1 |
Brunswig, D; Klingemann, HG; Liehr, H | 1 |
Deykin, D; Weinstein, MJ | 1 |
Gurewich, V; Lipinska, I; Lipinski, B | 1 |
Khvatova, EA | 1 |
Civardi, E; Dettori, AG; Megha, A; Pini, M; Ponari, O; Poti, R | 1 |
Martinez, J; Palascak, JE | 1 |
Bisset, J; Camous, JP; Delmont, J; Faure, X; Rampal, P | 1 |
Abe, T; Kazama, M | 1 |
López Borrasca, A; Marin, J; Rocha, E | 1 |
Kochen, M; Leonhardt, H; Palme, G | 1 |
Dreyfus, B; Gorin, NC; Gouault, M; Rochan, H | 1 |
Bettigole, RE; Cohn, M; Coleman, M; Finlayson, N; Pasmantier, M; Sadula, D | 1 |
Glauser, FL; Levine, RI; Otis, PT; Smith, WR | 1 |
Lustermans, FA; Russel, MG; van Wersch, JW | 1 |
Brown-Castillo, J; Fujii, Y; Mammen, EF; Nakumura, R; Ozawa, T; Sugawa, C | 1 |
Hino, F; Katayama, M; Kato, I; Kurome, T; Uchida, H; Yamamoto, K | 1 |
De Maat, MP; Knot, EA; Kroneman, H; Nieuwenhuizen, W; Van Bergen, PF | 1 |
Shi, JZ; Wang, QM | 1 |
Cioni, G; Cristani, A; Grandi, S; Mussini, C; Pentore, R; Tizzanini, W; Ventura, E; Zagni, G; Zeneroli, ML | 1 |
Antico, S; Callegari, F; Cappellato, M; Girolami, A; Pengo, V; Ruffato, G | 1 |
Acca, MR; Balestrieri, A; Mameli, G; Mamusa, AM; Marongiu, F; Medda, A; Mulas, G; Tronci, MB | 1 |
Gotoh, M; Kambayashi, J; Kobayashi, K; Monden, M; Mori, T; Okamura, J; Sakon, M | 1 |
Berg, PL; Frick, B; Kalk, JF; Thiele, H | 1 |
Lai, EC; Ng, IO; Ng, M; Wu, PC | 1 |
Hartleb, M; Kacperek, T; Nowak, A | 1 |
Aronson, D; Carr, JM; McDonagh, J; vanDeWater, L | 1 |
Bellisola, G; Casaril, M; Corrocher, R; Gabrielli, GB; Miatto, O; Nicoli, N | 1 |
Boeri, G; Girolami, A; Patrassi, GM; Sartori, MT; Sgarabotto, D; Sturniolo, G | 1 |
Cusumano, S; Galimberti, M; Parachini, F; Petrella, V; Rigotti, T | 1 |
Anderlini, D; Cioni, G; Cristani, A; Di Pancrazio, L; Grandi, S; Minetto, G; Ventura, E; Vezzelli, C; Zeneroli, ML; Zirilli, E | 1 |
Ohkita, T; Tanaka, M | 1 |
Aznar, J; Berenguer, J; Estellés, A; Garrido, G; Regañón, E; Vila, V | 1 |
Haeberli, A; Mombelli, G; Monotti, R; Straub, PW | 1 |
Kobayashi, N; Maekawa, T; Saitoh, H | 1 |
Francis, JL; Ingram, AJ; Simmonds, VJ | 1 |
Gans, H; Matsumoto, K; Mori, K | 1 |
Astedt, B; Nilsson, IM; Svanberg, L | 1 |
Kotschy, M | 1 |
Génova, V; Georgief, Z | 1 |
Brunt, PW; Mowat, NA; Ogston, D | 1 |
Bungert, HJ; Leonhardt, H | 5 |
Brueckner, GG; Mainwaring, RL | 1 |
Biggs, JC; Chesterman, CN; Lord, RS | 1 |
Baele, G; De Vos, M; Van Nimmen, L | 1 |
Alkjaersig, N; Fisher, S; Fletcher, AP; Sherry, S | 1 |
Cremer-Elfrink, HM; den Ottolander, GJ; Leijnse, B | 1 |
Gurewich, V; Hawiger, J; Niewiarowski, S; Thomas, DP | 1 |
Bloch, KJ; Colman, RW; Myers, AR; Niewiarowski, S; Thomas, DP | 1 |
Johnson, AJ; Merskey, C | 1 |
Blatný, J; Fischerová, E; Pelikán, V; Seidlová, V | 1 |
Judkiewicz, L; Olszañska, T; Tomaszewska, L | 1 |
Boulle, J; Buffet, C; Conard, J; Levy, VG; Samama, M | 1 |
Mester, L; Soria, J; Szabados, L | 1 |
Ansari, A; Silvis, SE | 1 |
Aiach, M; Busy, MF; Chanrion, C; Durand, H; Guéroult, N; Justin-Besançon, L; Leclerc, M; Rogé, J | 1 |
Wardle, EN | 1 |
Brunswig, D; Grün, M; Liehr, H; Thiel, H | 1 |
Al'pidovskiĭ, VK; Primak, A; Vogel, ChL | 1 |
Thomas, DP | 1 |
Blomhoff, JP; Gjone, E; Ritland, S; Skrede, S | 1 |
Fischer, M; Gauss, P; Korp, W; Nobis, H; Schnack, B; Weissmann, A | 1 |
Kreuning, J; Veltkamp, JJ | 1 |
Bungert, HJ | 1 |
Arnaud, P; Berthoux, F; Dechavanne, M; Thouverez, JP; Viala, JJ | 1 |
Rö, JS | 1 |
Collen, D; Vermylen, J; Verstraete, M | 1 |
Lasch, HG | 1 |
Cattan, D; Chardon, E; Gouault-Heilmann, M; Sultan, C; Yvart, J | 1 |
Gandolfo, GM | 1 |
Pierce, LE | 1 |
Perron, L; Thuot, C | 2 |
Javid, JP; Lackner, H | 1 |
Baele, G; Barbier, F; de Weerdt, GA; van Outryve, M | 1 |
Kourilsky, O; Leroy, C; Peltier, AP | 1 |
Cucuianu, M; Popescu, TA; Vasile, V | 1 |
Ananchenko, VG; Zaĭtsev, VF | 1 |
Zetterqvist, E | 1 |
Coon, WW; Iob, VL | 1 |
Gormsen, J | 1 |
Buraschi, J; Sack, ES | 2 |
Brodsky, I; Kahn, SB; Petkov, G; Ross, EM | 1 |
Blombäck, M; Norén, I | 1 |
Hällén, J; Laurell, CB | 1 |
Askherkhanov, RP; Safarov, SIu | 1 |
Brody, JI | 1 |
Collen, D; Tytgat, GN; Verstraete, M | 2 |
Bungert, HJ; Leonhardt, H; Schmidt, H; von Wolff, C | 1 |
Bennett, NB; Ogston, CM; Ogston, D | 1 |
Bilski-Pasquier, G; Girard, ML; Samama, M; Soria, C; Soria, J; Yver, J | 1 |
Rakhimov, SI; Tadzhiev, KT | 1 |
Grossi, CE; Prytz, B; Rousselot, LM | 1 |
Mammen, E; Walt, AJ; Wilson, RF | 1 |
Cash, JD; Das, PC | 1 |
Gerhold, WM; Mandel, EE | 1 |
Gormsen, J; Laursen, B | 1 |
Cain, GD; Jones, EA; Mayer, G | 1 |
Brodsky, I; Kahn, SB; Petkov, G; Ross, EM; Siegel, NH | 1 |
Losowsky, MS; Walls, WD | 2 |
Iutanova, II; Loginov, AS | 1 |
Gugler, E; Tschäppeler, H | 1 |
Genton, E; Wolf, PS | 1 |
Takahama, T | 1 |
Götz, H; Moussazadeh, M; Reichel, H | 1 |
Ryzhkova, LA | 1 |
Dumont, AE; Shinowara, GY; Stutman, LJ | 1 |
Holzknecht, F; Wilflingseder, P | 1 |
Daniele, F; Gillardi, U; Rizzi, D | 1 |
Brodsky, I; Dennis, LH | 1 |
Hajjar, GC; Moser, KM | 1 |
Blombäck, B; Carlson, LA; Franzén, S; Zetterqvist, E | 1 |
17 review(s) available for fibrinogen and Cirrhosis, Liver
Article | Year |
---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
The hemostatic and thrombotic complications of liver disease.
Topics: Anticoagulants; Blood Platelets; Blood Transfusion; Fibrinogen; Hemostasis; Heparin, Low-Molecular-Weight; Humans; Liver Cirrhosis; Thrombosis; von Willebrand Factor | 2021 |
[THE ROLE OF TRANSFORMING GROWTH FACTOR BETA 1 UNDER DISEASES OF LIVER].
Topics: Cytokines; Fibrinogen; Hepatic Stellate Cells; Hepatocytes; Humans; Liver; Liver Cirrhosis; Signal Transduction; Th1 Cells; Transforming Growth Factor beta1 | 2017 |
AGA Clinical Practice Update: Coagulation in Cirrhosis.
Topics: Anticoagulants; Antifibrinolytic Agents; Antithrombins; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Transfusion; Factor Xa Inhibitors; Fibrinogen; Hematocrit; Heparin; Humans; International Normalized Ratio; Liver Cirrhosis; Plasma; Platelet Count; Portal Vein; Thrombelastography; Thrombocytopenia; Thrombophilia; Thrombopoietin; Transfusion Reaction; Venous Thrombosis | 2019 |
Actions of thrombin in the interstitium.
Topics: Animals; Blood Coagulation; Extracellular Matrix; Extracellular Space; Fibrin; Fibrinogen; Fibroblasts; Fibrosis; Hemostasis; Humans; Liver Cirrhosis; Mice; Platelet Aggregation; Prothrombin; Pulmonary Fibrosis; Signal Transduction; Thrombin | 2016 |
Alterations in Fibrin Structure in Patients with Liver Diseases.
Topics: Fibrin; Fibrinogen; Hemorrhage; Humans; Liver Cirrhosis; Protein Processing, Post-Translational; Thrombosis | 2016 |
[THE PHYSIOPATHOLOGY OF FIBRINOLYSIS AND ITS CLINICAL AND THERAPEUTIC APPLICATIONS].
Topics: Blood Transfusion; Enzyme Inhibitors; Female; Fibrin; Fibrinogen; Fibrinolysin; Fibrinolysis; Hemostatics; Humans; Leukemia; Liver Cirrhosis; Male; Pathology; Physiology; Polycythemia Vera; Pregnancy; Pregnancy Complications; Pregnancy Complications, Hematologic; Prostatectomy; Prostatic Neoplasms; Prothrombin; Thrombin; Thromboplastin | 1964 |
PATHOLOGICAL FIBRINOLYSIS.
Topics: Aminocaproates; Aminocaproic Acid; Anticoagulants; Blood Coagulation Disorders; Blood Group Incompatibility; Deoxyribonuclease I; Drug Therapy; Female; Fibrinogen; Fibrinolysis; Heart, Artificial; Hematoma; Hematoma, Subdural; Humans; Leukemia; Liver Cirrhosis; Male; Menorrhagia; Peritoneum; Pleura; Postoperative Complications; Pregnancy; Pregnancy Complications; Prostatic Neoplasms; Snake Bites; Streptodornase and Streptokinase; Streptokinase; Thrombocytopenia; Urogenital System; Wounds and Injuries | 1964 |
[Disorders of hemostasis in liver cirrhosis. 2. Therapy].
Topics: Antithrombin III; Aprotinin; Blood Coagulation Disorders; Blood Transfusion; Disseminated Intravascular Coagulation; Erythrocyte Transfusion; Factor XIII; Fibrinogen; Heparin; Humans; Liver Cirrhosis; Platelet Transfusion; Prothrombin; Vitamin K | 1982 |
The dysfibrinogenaemias.
Topics: Afibrinogenemia; Blood Coagulation Tests; Carcinoma, Hepatocellular; Fibrinogen; Hemorrhage; Humans; Liver Cirrhosis; Liver Neoplasms; Mutation; Thrombosis | 2001 |
[Hemostasis disorders in liver cirrhosis].
Topics: Blood Coagulation Disorders; Blood Platelet Disorders; Blood Platelets; Factor IX; Factor VII; Factor XI; Factor XIII; Fibrinogen; Fibrinolysin; Humans; Hypersplenism; Liver; Liver Cirrhosis; Prothrombin Time | 1973 |
Hemostatic problems in liver surgery.
Topics: Animals; Blood Coagulation Disorders; Blood Coagulation Factors; Disseminated Intravascular Coagulation; Dogs; Factor IX; Factor V; Factor VII; Factor VIII; Factor X; Factor XI; Factor XII; Factor XIII; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Liver; Liver Cirrhosis; Liver Diseases; Liver Transplantation; Postoperative Complications; Prothrombin; Vitamin K Deficiency | 1973 |
Intravascular coagulation in liver disease.
Topics: Animals; Blood Coagulation Factors; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Disseminated Intravascular Coagulation; Ethanol; Fibrinogen; Half-Life; Hemostasis; Humans; Ligation; Liver; Liver Cirrhosis; Liver Diseases; Plasminogen; Portal Vein; Prothrombin | 1974 |
[The liver and plasma coagulation factors. Pathophysiology].
Topics: Antithrombins; Blood Coagulation Factors; Blood Coagulation Tests; Blood Platelets; Cholestasis; Disseminated Intravascular Coagulation; Esophageal and Gastric Varices; Factor IX; Factor V; Factor VIII; Factor XIII; Fibrinogen; Fibrinolysis; Hemorrhagic Disorders; Humans; Liver; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Liver Transplantation; Microcirculation; Transplantation, Homologous | 1973 |
[Significance of thrombogenesis in the pathogenesis of arteriosclerosis (literature review)].
Topics: Animals; Aorta; Arteriosclerosis; Blood Coagulation; Blood Coagulation Disorders; Blood Vessels; Endocrine Glands; Fibrin; Fibrinogen; Fibrinolysis; Hemorrhage; Heparin; Heparin Antagonists; Hepatitis; Humans; Lipid Metabolism; Lipoprotein Lipase; Liver; Liver Cirrhosis; Stress, Physiological; Thrombin; Thrombosis; Triglycerides | 1967 |
Elimination of iodine-labelled fibrinogen in intravascular coagulation and in the normal state. Experimental and clinical studies.
Topics: Aminocaproates; Animals; Anticoagulants; Antifibrinolytic Agents; Antigens; Aprotinin; Blood Cell Count; Blood Coagulation; Blood Coagulation Disorders; Blood Platelets; Chromatography; Chromatography, Gel; Dogs; Epidermolysis Bullosa; Fibrinogen; Fibrinolysis; Hematocrit; Immunoelectrophoresis; Injections, Intravenous; Iodine Isotopes; Liver Cirrhosis; Peptides; Polycythemia Vera; Potassium Iodide; Thrombin; Thromboplastin; Thrombosis | 1969 |
The liver and protein metabolism.
Topics: Amino Acids; Blood Proteins; Chemical and Drug Induced Liver Injury; Cystine; Diet Therapy; Dietary Proteins; Fatty Liver; Fibrinogen; Flocculation Tests; Humans; Liver; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Necrosis; Protein Biosynthesis; Protein Deficiency; Proteins; Prothrombin Time; RNA; Serum Albumin; Serum Globulins; Thyroid Hormones | 1964 |
6 trial(s) available for fibrinogen and Cirrhosis, Liver
Article | Year |
---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Therapeutic effect of traditional Chinese medicine on coagulation disorder and accompanying intractable jaundice in hepatitis B virus-related liver cirrhosis patients.
Topics: Adult; Bilirubin; Blood Circulation; Blood Coagulation; Blood Coagulation Disorders; Female; Fibrinogen; Hepatitis B; Hepatitis B virus; Humans; Jaundice; Liver Cirrhosis; Male; Medicine, Chinese Traditional; Middle Aged; Prothrombin Time; Retrospective Studies; Treatment Outcome | 2008 |
The coagulopathy of liver disease: does vitamin K help?
Topics: Adult; Aged; Biomarkers; Blood Coagulation Disorders; Blood Coagulation Tests; Carcinoma, Hepatocellular; Factor VII; Female; Fibrinogen; Hemorrhagic Disorders; Hepatitis B, Chronic; Hepatitis C; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Protein C; Protein Precursors; Protein S; Prothrombin; Treatment Outcome; Vitamin K; Young Adult | 2013 |
Recombinant human interleukin-11 improves thrombocytopenia in patients with cirrhosis.
Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Female; Fibrinogen; Follow-Up Studies; Hemoglobins; Humans; Interleukin-11; L-Lactate Dehydrogenase; Leukocyte Count; Liver Cirrhosis; Male; Middle Aged; Platelet Count; Recombinant Proteins; Thrombocytopenia; Treatment Outcome | 2003 |
Interleukin-6: an early marker of bacterial infection in decompensated cirrhosis.
Topics: Adult; Aged; Bacterial Infections; Biomarkers; C-Reactive Protein; Fibrinogen; Follow-Up Studies; Humans; Interleukin-6; Liver Cirrhosis; Middle Aged; Prognosis; Time Factors; Tumor Necrosis Factor-alpha | 1994 |
The influence of antithrombin III (AT III) substitution to supranormal activities on systemic procoagulant turnover in patients with end-stage chronic liver disease.
Topics: Adult; Antithrombin III; Blood Coagulation; Chronic Disease; Dose-Response Relationship, Drug; Female; Fibrinogen; Humans; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Partial Thromboplastin Time; Prospective Studies; Prothrombin Time; Serine Proteinase Inhibitors | 1997 |
234 other study(ies) available for fibrinogen and Cirrhosis, Liver
Article | Year |
---|---|
Nonmalignant portal vein thrombi in patients with cirrhosis consist of intimal fibrosis with or without a fibrin-rich thrombus.
Topics: Anticoagulants; Fibrin; Fibrinogen; Humans; Liver Cirrhosis; Portal Vein; Retrospective Studies; Thrombosis; Venous Thrombosis; von Willebrand Factor | 2022 |
Fibrin clot quality in acutely ill cirrhosis patients: Relation with outcome and improvement with coagulation factor concentrates.
Topics: Blood Coagulation; Blood Coagulation Factors; Fibrin; Fibrinogen; Humans; Liver Cirrhosis; Thrombosis | 2022 |
Quality Assessment and Clinical Utility of Plasma Obtained Via Apheresis vs That Obtained from Whole Blood.
Topics: Blood Component Removal; Factor V; Fibrinogen; Humans; Liver Cirrhosis; Plasma; Purpura, Thrombotic Thrombocytopenic | 2022 |
Characterization of Biomarkers of Hemostasis and Bleeding-Related Outcomes in Children With Cirrhosis.
Topics: Adult; Biomarkers; Child; Fibrinogen; Hemorrhage; Hemostasis; Humans; Liver Cirrhosis; Retrospective Studies | 2022 |
B cell-activating factor is involved in thrombocytopenia in patients with liver cirrhosis.
Topics: Autoantibodies; B-Cell Activating Factor; Blood Platelets; Fibrinogen; Humans; Liver Cirrhosis; Platelet Glycoprotein GPIIb-IIIa Complex; Purpura, Thrombocytopenic, Idiopathic; Thrombocytopenia | 2022 |
Evaluation of Serum FGL1 as Diagnostic Markers for HBV-Related Hepatocellular Carcinoma.
Topics: alpha-Fetoproteins; Biomarkers, Tumor; Carcinoma, Hepatocellular; Fibrinogen; Hepatitis B virus; Humans; Liver Cirrhosis; Liver Neoplasms | 2023 |
Fibrinogen-like protein 2 promotes proinflammatory macrophage polarization and mitochondrial dysfunction in liver fibrosis.
Topics: Fibrinogen; Fibrosis; Hepatitis B; Humans; Inflammation; Liver Cirrhosis; Macrophage Activation; Macrophages; Proto-Oncogene Proteins c-akt | 2023 |
Population pharmacokinetic modelling of fibrinogen in patients with congenital or acquired-chronic or acute-hypofibrinogenaemia.
Topics: Afibrinogenemia; Blood Coagulation; Fibrinogen; Hemorrhage; Humans; Liver Cirrhosis | 2023 |
Fibrin clots from patients with acute-on-chronic liver failure are weaker than those from healthy individuals and patients with sepsis without underlying liver disease.
Topics: Acute-On-Chronic Liver Failure; Fibrin; Fibrinogen; Fibrinolysis; Fibrosis; Hemostatics; Humans; Liver Cirrhosis; Sepsis; Thrombosis | 2023 |
A model to predict early hepatic encephalopathy in patients undergoing transjugular intrahepatic portosystemic shunt.
Topics: Adult; Aged; Aged, 80 and over; Female; Fibrinogen; Hepatic Encephalopathy; Humans; Hypertension, Portal; Liver Cirrhosis; Logistic Models; Male; Middle Aged; Portasystemic Shunt, Transjugular Intrahepatic; Predictive Value of Tests; Preoperative Period; Reference Values; Retrospective Studies; Risk Assessment; Risk Factors; ROC Curve; Severity of Illness Index; Treatment Outcome; Young Adult | 2019 |
Plasma Fibrinogen-Like 1 as a Potential Biomarker for Radiation-Induced Liver Injury.
Topics: Animals; Apoptosis; Autophagy; Biomarkers; Cells, Cultured; Fibrinogen; Hepatocytes; Humans; Liver; Liver Cirrhosis; Male; Mice; Mice, Inbred BALB C; Radiation Injuries, Experimental; Radiation, Ionizing | 2019 |
Transfusion with Cryoprecipitate for Very Low Fibrinogen Levels Does Not Affect Bleeding or Survival in Critically Ill Cirrhosis Patients.
Topics: Afibrinogenemia; Biomarkers; Blood Transfusion; Critical Illness; Down-Regulation; Esophageal and Gastric Varices; Factor VIII; Female; Fibrinogen; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Intensive Care Units; Liver Cirrhosis; Male; Middle Aged; Patient Admission; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome | 2021 |
Copper concentrations are prevalently associated with antithrombin III, but also with prothrombin time and fibrinogen in patients with liver cirrhosis: A cross-sectional retrospective study.
Topics: Albumins; Antithrombin III; Blood Coagulation Factors; Copper; Cross-Sectional Studies; Fibrinogen; Hemostatics; Humans; Liver Cirrhosis; Prothrombin Time; Retrospective Studies | 2021 |
Observed incidence of hypofibrinogenemia in cirrhotic patients.
Topics: Afibrinogenemia; Fibrinogen; Humans; Incidence; Liver Cirrhosis | 2021 |
High-fat diet-induced plasma protein and liver changes in obese rats can be attenuated by melatonin supplementation.
Topics: alpha 1-Antitrypsin; Animals; Biomarkers; Blood Glucose; Blood Proteins; Body Weight; Complement C4; Complement Factor B; Diet, High-Fat; Diet, High-Protein; Dietary Carbohydrates; Disease Models, Animal; Fatty Liver; Fibrinogen; Inflammation; Insulin; Liver; Liver Cirrhosis; Male; Mannose-Binding Lectin; Melatonin; Obesity; Plasminogen; Proteomics; Rats; Rats, Wistar | 2017 |
Portal Vein Thrombosis Repeatedly Observed in a Cirrhotic Patient with Antiphospholipid Antibody Syndrome.
Topics: Antiphospholipid Syndrome; Fibrin; Fibrinogen; Humans; Liver Cirrhosis; Male; Middle Aged; Portal Vein; Tomography, X-Ray Computed; Venous Thrombosis | 2016 |
The primary haemostasis is more preserved in thrombocytopenic patients with liver cirrhosis than cancer.
Topics: Adult; Factor VIII; Female; Fibrinogen; Hemostasis; Humans; Liver Cirrhosis; Male; Middle Aged; Neoplasms; Partial Thromboplastin Time; Platelet Aggregation; Platelet Count; Thrombin; Thrombocytopenia | 2018 |
Activation of Hepatic Stellate Cells During Liver Carcinogenesis Requires Fibrinogen/Integrin αvβ5 in Zebrafish.
Topics: Animals; Carcinogenesis; Carcinoma, Hepatocellular; Disease Progression; Fibrinogen; Hepatic Stellate Cells; Hepatocytes; Humans; Liver; Liver Cirrhosis; Liver Neoplasms; Oncogenes; Receptors, Vitronectin; Signal Transduction; Zebrafish | 2018 |
Low Fibrinogen Levels Are Associated with Bleeding After Varices Ligation in Thrombocytopenic Cirrhotic Patients.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Blood Coagulation; Down-Regulation; Endoscopy; Esophageal and Gastric Varices; Female; Fibrinogen; Gastrointestinal Hemorrhage; Humans; International Normalized Ratio; Ligation; Liver Cirrhosis; Male; Middle Aged; Platelet Count; Postoperative Hemorrhage; Risk Assessment; Risk Factors; Thrombocytopenia; Time Factors; Treatment Outcome | 2018 |
Ziziphus spina-christi leaf extract ameliorates schistosomiasis liver granuloma, fibrosis, and oxidative stress through downregulation of fibrinogenic signaling in mice.
Topics: Animals; Disease Models, Animal; Down-Regulation; Drug Administration Schedule; Fibrinogen; Gene Expression Regulation; Lipid Peroxidation; Liver Cirrhosis; Liver Function Tests; Male; Mice; NF-E2-Related Factor 2; Oxidative Stress; Plant Extracts; Plant Leaves; Schistosomiasis mansoni; Signal Transduction; Ziziphus | 2018 |
Fast and facile analysis of glycosylation and phosphorylation of fibrinogen from human plasma-correlation with liver cancer and liver cirrhosis.
Topics: Carcinoma, Hepatocellular; Fibrinogen; Glycosylation; Humans; Liver Cirrhosis; Liver Neoplasms; Phosphorylation; Protein Processing, Post-Translational; Reference Standards; Time Factors | 2018 |
Soluble fibrinogen-like protein 2 levels in patients with hepatitis B virus-related liver diseases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Carcinoma, Hepatocellular; Case-Control Studies; Disease Progression; Female; Fibrinogen; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Solubility; Young Adult | 2018 |
Novel insights into the assessment of risk of upper gastrointestinal bleeding in decompensated cirrhotic children.
Topics: Blood Coagulation; Child; Child, Preschool; End Stage Liver Disease; Endoscopy; Esophageal and Gastric Varices; Female; Fibrinogen; Gastrointestinal Hemorrhage; Hemostasis; Humans; Hypertension, Portal; Infant; Liver Cirrhosis; Liver Transplantation; Male; Platelet Aggregation; Predictive Value of Tests; Prospective Studies; Risk Factors; Waiting Lists | 2019 |
Perioperative hemostatic management in the cirrhotic patient: a position paper on behalf of the Liver Intensive Care Group of Europe (LICAGE).
Topics: Anemia; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Coagulation Tests; Blood Loss, Surgical; Deamino Arginine Vasopressin; Elective Surgical Procedures; Europe; Factor VIIa; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Hemostasis; Hemostatic Techniques; Hemostatics; Humans; Liver Cirrhosis; Perioperative Care; Plasma; Platelet Function Tests; Platelet Transfusion; Postoperative Hemorrhage; Recombinant Proteins | 2019 |
A non-autonomous role of MKL1 in the activation of hepatic stellate cells.
Topics: Animals; Cells, Cultured; Connective Tissue Growth Factor; Fibrinogen; Glucose; HEK293 Cells; Hep G2 Cells; Hepatic Stellate Cells; Hepatocytes; Humans; Liver; Liver Cirrhosis; Male; Mice; Mice, Inbred C57BL; Models, Animal; RNA, Small Interfering; Smad3 Protein; Trans-Activators; Transcription Factor AP-1; Up-Regulation | 2019 |
The antifibrinolytic drug tranexamic acid reduces liver injury and fibrosis in a mouse model of chronic bile duct injury.
Topics: 1-Naphthylisothiocyanate; Animals; Antifibrinolytic Agents; Bile Duct Diseases; Collagen Type I; Disease Models, Animal; Fibrin; Fibrinogen; Liver; Liver Cirrhosis; Mice; Mice, Inbred C57BL; Mice, Knockout; Plasminogen Activator Inhibitor 1; Tranexamic Acid | 2014 |
Lack of a 5.9 kDa peptide C-terminal fragment of fibrinogen α chain precedes fibrosis progression in patients with liver disease.
Topics: Disease Progression; Female; Fibrinogen; Hep G2 Cells; Hepacivirus; Hepatitis C; Humans; Liver; Liver Cirrhosis; Liver Diseases; Liver Transplantation; Male; Middle Aged; Peptide Fragments | 2014 |
The effects of in vitro hemodilution and fibrinogen concentrate substitution on thromboelastometry analysis in patients qualified for liver transplantation - preliminary results.
Topics: Adult; Blood Coagulation Disorders; Blood Coagulation Tests; Case-Control Studies; Female; Fibrinogen; Hemodilution; Hemorrhage; Hemostasis; Hemostatics; Humans; Hydroxyethyl Starch Derivatives; In Vitro Techniques; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Prospective Studies; Thrombelastography | 2014 |
Fibrinogen storage disease and cirrhosis associated with hypobetalipoproteinemia owing to fibrinogen Aguadilla in a Turkish child.
Topics: Afibrinogenemia; Carbamazepine; Child, Preschool; Cholagogues and Choleretics; Cytochrome P-450 CYP3A Inducers; Female; Fibrinogen; Humans; Hypobetalipoproteinemias; Liver; Liver Cirrhosis; Mutation, Missense; Treatment Outcome; Ursodeoxycholic Acid | 2015 |
[Liver tissue regeneration under the influence of cryoprecipitate and alloplant].
Topics: Adolescent; Adult; Aged; Allografts; Cell- and Tissue-Based Therapy; Factor VIII; Female; Fibrinogen; Fibronectins; Humans; Liver Cirrhosis; Liver Regeneration; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Young Adult | 2015 |
Hemorrhagic Complications Following Abdominal Paracentesis in Acute on Chronic Liver Failure: A Propensity Score Analysis.
Topics: Acute-On-Chronic Liver Failure; Adult; Female; Fibrinogen; Hemorrhage; Humans; Liver Cirrhosis; Longitudinal Studies; Male; Middle Aged; Paracentesis; Prognosis; Propensity Score; Prothrombin; Retrospective Studies; Risk Factors | 2015 |
Is Hydroxyethyl Starch Irrelevant to Hemostasis in Patients Undergoing Liver Transplantation?--In vitro Analysis Based on Thromboelastometry.
Topics: Blood Coagulation Tests; Blood Loss, Surgical; Cohort Studies; Female; Fibrinogen; Fluid Therapy; Follow-Up Studies; Hemodilution; Hemostasis; Hemostatic Techniques; Humans; Hydroxyethyl Starch Derivatives; In Vitro Techniques; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Risk Assessment; Thrombelastography; Treatment Outcome | 2015 |
[Hepatopulmonary syndrome-related changes in D-dimer, prothrombin time, fibrinogen, CD4 and CD8 in a rat model system].
Topics: Animals; CD4 Antigens; CD4-CD8 Ratio; CD8 Antigens; Disease Models, Animal; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hepatopulmonary Syndrome; Liver Cirrhosis; Lung; Male; Prothrombin Time; Rats; Rats, Sprague-Dawley | 2015 |
Fibrinogen as an independent predictor of mortality in decompensated cirrhosis and bleeding.
Topics: Fibrinogen; Hemorrhage; Humans; Liver Cirrhosis | 2017 |
Preoperatively staging liver fibrosis using noninvasive method in hepatitis B virus-infected hepatocellular carcinoma patients.
Topics: Adult; Area Under Curve; Bilirubin; Biomarkers; Carcinoma, Hepatocellular; Female; Fibrinogen; Hepatectomy; Hepatitis B, Chronic; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Platelet Count; Preoperative Period; Prospective Studies; Prothrombin; Regression Analysis; Retrospective Studies | 2017 |
Risks and benefits of transcatheter thrombolytic therapy in patients with splanchnic venous thrombosis.
Topics: Adult; Budd-Chiari Syndrome; Female; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Humans; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Patient Selection; Portal Vein; Portasystemic Shunt, Transjugular Intrahepatic; Retrospective Studies; Risk Assessment; Splanchnic Circulation; Thrombolytic Therapy; Treatment Outcome; Vascular Patency; Venous Thrombosis | 2008 |
Rapamycin inhibits hepatic fibrosis in rats by attenuating multiple profibrogenic pathways.
Topics: Animals; Cell Differentiation; Cell Proliferation; Epithelium; Fibrinogen; Fibrosis; Immunosuppressive Agents; Liver; Liver Cirrhosis; Male; Mesoderm; Models, Biological; Rats; Rats, Wistar; Sirolimus; Stem Cells | 2009 |
Rapid determination of blood coagulation factor XIII activity using protein arrays for serodiagnosis of human plasma.
Topics: Amines; Biomarkers, Tumor; Biotin; Blood Specimen Collection; Carcinoma, Hepatocellular; Factor XIII; Fibrinogen; Hepatitis; Humans; Immobilized Proteins; Isoniazid; Limit of Detection; Liver Cirrhosis; Liver Neoplasms; Protein Array Analysis; Reproducibility of Results; Serologic Tests; Time Factors | 2011 |
Fibrinogen deficiency increases liver injury and early growth response-1 (Egr-1) expression in a model of chronic xenobiotic-induced cholestasis.
Topics: 1-Naphthylisothiocyanate; Afibrinogenemia; Aged; Animals; Bile Ducts; Cholestasis; Chronic Disease; Collagen; Diet; Disease Models, Animal; Early Growth Response Protein 1; Feeding Behavior; Female; Fibrin; Fibrinogen; Gene Expression Regulation; Humans; Hyperplasia; Inflammation; Liver; Liver Cirrhosis; Male; Mice; Middle Aged; Neutrophils; Xenobiotics | 2011 |
Importance of certain pro-inflammatory indices in patients with liver cirrhosis and bacterial infection on prognosis and course of the disease.
Topics: Bacterial Infections; Biomarkers; Blood Sedimentation; C-Reactive Protein; Female; Fibrinogen; Humans; Inflammation; Leukocyte Count; Liver Cirrhosis; Male; Middle Aged; Prognosis; Survival Rate | 2012 |
Clinical significance of haemostatic tests in chronic liver disease.
Topics: Adult; Antithrombin III; Biomarkers; Blood Coagulation Tests; Chronic Disease; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; International Normalized Ratio; Liver Cirrhosis; Male; Middle Aged; Partial Thromboplastin Time; Protein C | 2012 |
Serum fibrinogen alpha C-chain 5.9 kDa fragment as a biomarker for early detection of hepatic fibrosis related to hepatitis C virus.
Topics: Adult; Aged; Biomarkers; Blood Specimen Collection; Early Diagnosis; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Hepacivirus; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Male; Middle Aged; Peptide Fragments; Reference Values; ROC Curve; Temperature; Time Factors | 2013 |
[Electrophoretic determination of fibrinogen in hepatic cirrhosis and in other pathological conditions].
Topics: Coagulants; Electrophoresis; Fibrinogen; Humans; Liver Cirrhosis | 1953 |
[Fibrinogen content of the blood plasma in liver cirrhosis].
Topics: Fibrinogen; Humans; Liver Cirrhosis; Plasma | 1954 |
[Possibility of differentiation of development of cirrhosis and neoplasms in ascitic fluid through determination of certain blood coagulation factors in ascitic fluid].
Topics: Ascites; Ascitic Fluid; Blood Coagulation Factors; Diagnosis, Differential; Fibrinogen; Humans; Liver Cirrhosis; Liver Neoplasms; Neoplasms; Prothrombin Time | 1958 |
[Indices of blood coagulation processes (fibrinogen, prothrombin, factor V and factor VII) in the evaluation of functional conditions of the liver in Botkin's disease and cirrhosis].
Topics: Blood Coagulation; Factor V; Factor VII; Fibrinogen; Hepatitis; Hepatitis A; Humans; Liver Cirrhosis; Prothrombin | 1961 |
CIRCULATING FIBRINOLYTIC ACTIVATOR AND HEMORRHAGIC DIATHESIS.
Topics: Aminocaproates; Aminocaproic Acid; Blood Coagulation Tests; Fibrinogen; Fibrinolysis; Hemorrhagic Disorders; Humans; Liver Cirrhosis; Portacaval Shunt, Surgical; Postoperative Complications | 1963 |
[CHANGES IN LIVER PROTEINS AND BLOOD PROTEINS IN EXPERIMENTAL LIVER CIRRHOSIS AND FOLLOWING DECORTIN AND ANABOLIC STEROID TREATMENT].
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Blood Protein Electrophoresis; Ceruloplasmin; Clinical Enzyme Tests; Cytoplasm; D-Alanine Transaminase; Fibrinogen; Iron; Liver; Liver Cirrhosis; Liver Cirrhosis, Experimental; Mitochondria; Nandrolone; Oxidoreductases; Prednisone; Proteins; Prothrombin; Rats; Research; Sulfacetamide | 1963 |
COAGULATION STUDIES IN LIVER DISEASE.
Topics: Blood Coagulation; Blood Coagulation Factors; Enzyme Inhibitors; Factor IX; Factor V; Factor VIII; Fibrinogen; Fibrinolysis; Hepatitis; Humans; Jaundice; Jaundice, Obstructive; Liver Cirrhosis; Liver Diseases; Prothrombin | 1964 |
FIBRINOGEN CATABOLISM IN HUMANS.
Topics: Blood Proteins; Blood Volume; Carcinoma; Fibrinogen; Geriatrics; Humans; Iodine Isotopes; Liver Cirrhosis; Liver Neoplasms; Physiology; Proteins; Tuberculosis; Tuberculosis, Pulmonary | 1964 |
TURNOVER AND DISTRIBUTION OF 131-IODINE-LABELLED HUMAN FIBRINOGEN.
Topics: Arteriosclerosis; Blood Coagulation Tests; Coronary Disease; Diabetes Mellitus; Fibrinogen; Geriatrics; Humans; Intervertebral Disc Displacement; Iodine; Iodine Isotopes; Liver Cirrhosis; Lung Neoplasms; Metabolism; Radiometry; Thrombophlebitis; Thrombosis | 1964 |
FIBRINOLYTIC BLEEDING AND ITS MANAGEMENT.
Topics: Aminocaproates; Aminocaproic Acid; Blood Coagulation Tests; Fibrinogen; Fibrinolysis; Hemorrhagic Disorders; Humans; Liver Cirrhosis; Niacin; Nicotinic Acids | 1964 |
Abnormal hemorheological properties in patients with compensated and decompensated hepatic cirrhosis.
Topics: Adolescent; Adult; Blood Proteins; Blood Viscosity; Female; Fibrinogen; Hematocrit; Hemorheology; Humans; Liver Cirrhosis; Male; Middle Aged; N-Acetylneuraminic Acid; Patient Selection; Protein Binding; Reference Values | 2003 |
The answer: angiotensin II. The question: what do inflammation, oxidant stress and fibrogenesis have in common?
Topics: Angiotensin II; Fibrinogen; Humans; Inflammation; Liver Cirrhosis; Oxidative Stress; Vasoconstriction | 2004 |
[The relationship between hemostatic changes in liver cirrhosis patients with different degrees of liver lesions in reference to Child-Pugh scores].
Topics: Adult; Aged; Antithrombins; Blood Coagulation Factors; Female; Fibrinogen; Hemostasis; Hepatitis B, Chronic; Humans; Liver Cirrhosis; Male; Middle Aged; Prothrombin Time; Severity of Illness Index | 2005 |
Therapeutic effects and possible mechanisms of a snake venom preparation in the fibrotic rat liver.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile; Carbon Tetrachloride; Dose-Response Relationship, Drug; Fibrinogen; Liver; Liver Circulation; Liver Cirrhosis; Male; Membrane Transport Proteins; Microcirculation; Organic Anion Transporters, Sodium-Dependent; Organic Anion Transporters, Sodium-Independent; Rats; Rats, Wistar; RNA, Messenger; Snake Venoms; Symporters; Taurocholic Acid; Thromboxane B2 | 2005 |
Vascular invasion and herniation by hepatocellular carcinoma in cirrhosis: A wolf in sheep's clothing?
Topics: Actins; Adult; Biomarkers, Tumor; Carcinoma, Hepatocellular; Endothelium, Vascular; Factor XIIIa; Female; Fibrin; Fibrinogen; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Neoplastic Cells, Circulating; Receptors, Complement 3b | 2005 |
Importance of anticoagulant proteins in chronic liver diseases.
Topics: Adult; Aged; Antithrombins; Bilirubin; Biomarkers; Blood Coagulation Factor Inhibitors; Blood Coagulation Tests; Case-Control Studies; Enzyme-Linked Immunosorbent Assay; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Middle Aged; Protein C; Protein S; Serum Albumin; Severity of Illness Index | 2005 |
Fibrinogen storage disease without hypofibrinogenemia associated with estrogen therapy.
Topics: Adult; Endoplasmic Reticulum; Estrogen Replacement Therapy; Female; Fibrinogen; Humans; Immunohistochemistry; Inclusion Bodies; Liver; Liver Cirrhosis; Metabolic Diseases; Microscopy, Electron; Necrosis | 2005 |
Fibrin stabilizing factor (factor XIII) activity in liver cirrhosis.
Topics: Case-Control Studies; Factor XIII; Fibrinogen; Humans; Liver Cirrhosis; Severity of Illness Index | 1967 |
Fibrinogen gamma375 arg-->trp mutation (fibrinogen aguadilla) causes hereditary hypofibrinogenemia, hepatic endoplasmic reticulum storage disease and cirrhosis.
Topics: Adult; Afibrinogenemia; Amino Acid Sequence; Amino Acid Substitution; Arginine; Endoplasmic Reticulum; Family Health; Fibrinogen; Hepatocytes; Humans; Inclusion Bodies; Liver; Liver Cirrhosis; Male; Middle Aged; Molecular Sequence Data; Mutation, Missense; Point Mutation; Tryptophan | 2006 |
JunD is a profibrogenic transcription factor regulated by Jun N-terminal kinase-independent phosphorylation.
Topics: Actins; Alanine Transaminase; Animals; Anthracenes; Carbon Tetrachloride Poisoning; Extracellular Signal-Regulated MAP Kinases; Fibrinogen; Flavonoids; Humans; JNK Mitogen-Activated Protein Kinases; Liver; Liver Cirrhosis; Mice; Phosphorylation; Proto-Oncogene Proteins c-jun; Rats; Signal Transduction; Tissue Inhibitor of Metalloproteinase-1; Transcription Factors; Transcription, Genetic | 2006 |
Comparison of rheological parameters in patients with post hepatitic and alcoholic cirrhosis.
Topics: Blood Viscosity; Chronic Disease; Erythrocyte Count; Erythrocyte Deformability; Fibrinogen; gamma-Globulins; Hemorheology; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Reference Values | 2007 |
To aggregate or not to aggregate...
Topics: Afibrinogenemia; Exons; Female; Fibrinogen; Heterozygote; Humans; Introns; Liver Cirrhosis; Mutation; Mutation, Missense; Platelet Aggregation; Protein Structure, Tertiary | 2007 |
Interferon-gamma exacerbates liver damage, the hepatic progenitor cell response and fibrosis in a mouse model of chronic liver injury.
Topics: Animals; Chemical and Drug Induced Liver Injury; Chronic Disease; Diet; Disease Models, Animal; Fibrinogen; Hepatocytes; Inflammation; Interferon-gamma; Liver Cirrhosis; Mice; Recombinant Proteins; Stem Cells | 2007 |
[Ruptured cirrhotic nodulus treated with collagen patch].
Topics: Abdomen, Acute; Aprotinin; Drug Combinations; Fibrinogen; Hemostasis, Surgical; Humans; Liver Cirrhosis; Male; Middle Aged; Rupture, Spontaneous; Thrombin; Treatment Outcome | 2007 |
The importance of simple coagulation tests (fibrinogen assays and thrombin coagulase clotting time) in the diagnosis of liver cancer.
Topics: Adult; Afibrinogenemia; Aged; Blood Coagulation Tests; Carcinoma, Hepatocellular; Diagnosis, Differential; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Thrombin Time | 1984 |
A clinical evaluation of serum alpha-1-antichymotrypsin levels in liver disease and cancers.
Topics: alpha 1-Antichymotrypsin; alpha-Fetoproteins; Blood Sedimentation; Carcinoembryonic Antigen; Carcinoma, Hepatocellular; Chymotrypsin; Fibrinogen; Humans; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Sialic Acids | 1981 |
[Studies on the usefulness of the gamma globulin-fibrinogen index in differential diagnosis of liver diseases].
Topics: Adolescent; Adult; Aged; Diagnosis, Differential; Female; Fibrinogen; gamma-Globulins; Hepatitis; Hepatitis B; Hepatitis, Chronic; Humans; Liver Cirrhosis; Male; Middle Aged | 1983 |
[Diagnostic significance of proteolytic breakdown products of fibrinogen and fibrin].
Topics: Disseminated Intravascular Coagulation; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Fibrinolysis; Glomerulonephritis; Hemostasis; Humans; Liver Cirrhosis; Postoperative Complications; Pulmonary Embolism; Thrombin; Thromboembolism; Thrombophlebitis | 1984 |
Fibrinogen-bound sialic acid levels in the dysfibrinogenaemia of liver disease.
Topics: Afibrinogenemia; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Liver Cirrhosis; Liver Diseases; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Sialic Acids; Thrombin Time | 1982 |
Study on coagulation profile of patients with cirrhosis of the liver undergoing elective fibreoptic injection sclerotherapy of oesophageal varices.
Topics: Adult; Aged; Antithrombin III; Blood Coagulation Factors; Esophageal and Gastric Varices; Female; Fiber Optic Technology; Fibrinogen; Humans; Liver Cirrhosis; Male; Middle Aged; Platelet Count; Sclerosing Solutions; Time Factors | 1984 |
[Markerfunction of crosslinked fibrin derivatives in ascitic fluid from patients with ovarian cancer: a comparison with ascitic fluid in liver cirrhosis].
Topics: Ascites; Ascitic Fluid; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinopeptide A; Humans; Liver Cirrhosis; Ovarian Neoplasms | 1983 |
Prekallikrein behaviour in chronic active hepatitis and in cirrhotic patients.
Topics: Adult; Aged; alpha-2-Antiplasmin; Antithrombin III; Blood Coagulation; Blood Coagulation Tests; Female; Fibrinogen; Hepatitis, Chronic; Humans; Kallikreins; Liver Cirrhosis; Male; Middle Aged; Plasminogen; Platelet Count; Prekallikrein | 1984 |
A lysine-absorbable plasminogen activator is elevated in conditions associated with increased fibrinolytic activity.
Topics: Adsorption; Adult; Animals; Cattle; Fibrinogen; Fibrinolysis; Forearm; Humans; Liver Cirrhosis; Lysine; Plasminogen Activators; Serum Albumin; Serum Globulins; Thrombophlebitis | 1981 |
Disseminated intravascular coagulation following peritoneo-venous (LeVeen) shunt.
Topics: Adult; Aged; Ascites; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Partial Thromboplastin Time; Peritoneovenous Shunt; Platelet Count; Postoperative Complications; Prospective Studies; Prothrombin Time; Thrombin Time; Vascular Surgical Procedures | 1981 |
Effects of splenectomy on blood coagulation and fibrinolysis in patients with liver cirrhosis: possible role of the spleen in haemostasis.
Topics: Adult; Aged; Blood Coagulation; Female; Fibrinogen; Fibrinolysis; Fluorescent Antibody Technique; Hemostasis; Humans; Liver Cirrhosis; Male; Middle Aged; Organ Size; Platelet Count; Spleen; Splenectomy; Time Factors | 1980 |
Kinetic and functional studies of platelets, fibrinogen, and plasminogen in patients with hepatic cirrhosis.
Topics: Blood Platelets; Fibrinogen; Hemostasis; Heparin; Humans; Kinetics; Liver; Liver Cirrhosis; Plasminogen; Platelet Aggregation; Platelet Count; Protein Biosynthesis; Prothrombin Time | 1982 |
Reduced histidine-rich glycoprotein levels in plasma of patients with advanced liver cirrhosis. Possible implications for enhanced fibrinolysis.
Topics: Adult; Aged; alpha-2-Antiplasmin; Antithrombin III; Female; Fibrinogen; Fibrinolysis; Glycoproteins; Humans; Liver Cirrhosis; Male; Middle Aged; Plasminogen; Proteins; Serum Albumin | 1982 |
Antithrombin III transfusion in patients with hepatic cirrhosis.
Topics: Adult; Aged; Antithrombin III; Antithrombin III Deficiency; Blood Coagulation; Female; Fibrinogen; Half-Life; Humans; Liver Cirrhosis; Male; Middle Aged | 1982 |
Significance of plasma fibrinopeptide A and high molecular weight fibrinogen in patients with liver cirrhosis.
Topics: Female; Fibrinogen; Fibrinopeptide A; Heparin; Humans; Liver Cirrhosis; Male; Molecular Weight | 1982 |
[Changes in fibrin formation in liver cirrhosis].
Topics: Adult; Blood Coagulation Disorders; Fetal Blood; Fibrin; Fibrinogen; Humans; Infant, Newborn; Liver; Liver Cirrhosis | 1982 |
Increased plasma antithrombin III level in hyperlipidemic subjects.
Topics: Adult; Aged; Antithrombin III; Butyrylcholinesterase; Cholesterol; Female; Fibrinogen; Humans; Hyperlipidemias; Liver Cirrhosis; Male; Middle Aged; Obesity; Triglycerides | 1981 |
[Electrophoretic changes in fibrinogen in liver cirrhosis].
Topics: Blood Protein Electrophoresis; Fibrinogen; Hepatitis, Viral, Human; Humans; Immunoelectrophoresis; Liver Cirrhosis | 1981 |
Importance of the liver in the regulation of platelet activity: effect of its functional exclusion (Eck fistula).
Topics: Adenosine Diphosphate; Animals; Binding Sites; Blood Coagulation; Blood Platelets; Fibrinogen; Humans; Liver; Liver Cirrhosis; Platelet Aggregation; Platelet Count; Portacaval Shunt, Surgical; Rats | 1980 |
Structure of fibrin and fibrinmonomer in renal and hepatic failure.
Topics: Factor XIII; Fibrin; Fibrinogen; Humans; Kidney Failure, Chronic; Liver Cirrhosis; Protein Conformation | 1980 |
Hemostatic function in cancer patients.
Topics: Adolescent; Adult; Aged; Antithrombin III; Blood Coagulation Tests; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Liver Cirrhosis; Male; Middle Aged; Neoplasm Metastasis; Neoplasms | 1980 |
Aprotinin efficacy on intraoperative bleeding and transfusion requirements in orthotopic liver transplantation.
Topics: Adult; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Blood Transfusion, Autologous; Erythrocyte Transfusion; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Plasma; Platelet Transfusion | 1994 |
Acute phase response after liver transplantation for fulminant hepatic failure and cirrhosis.
Topics: Acute-Phase Reaction; Adult; alpha 1-Antitrypsin; C-Reactive Protein; Female; Fibrinogen; Hepatic Encephalopathy; Humans; Interleukin-6; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged | 1995 |
Measuring plasma fibrinogen levels in patients with liver cirrhosis. The occurrence of proteolytic fibrin(ogen) degradation products and their influence on several fibrinogen assays.
Topics: Child; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Liver Cirrhosis | 1995 |
[Fibrinolysis in chronic liver diseases studied by in vitro blood coagulation tests].
Topics: Adult; Aged; Antifibrinolytic Agents; Blood Coagulation Tests; Cholestasis; Chronic Disease; Female; Fibrinogen; Fibrinolysis; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Liver Cirrhosis, Biliary; Male; Middle Aged; Prognosis; Tissue Plasminogen Activator | 1994 |
Relationship between lipoprotein(a) levels in serum and some indices of protein synthesis in liver cirrhosis.
Topics: Apolipoprotein B-100; Apolipoproteins B; Cholesterol; Female; Fibrinogen; Humans; Lipoprotein(a); Liver; Liver Cirrhosis; Male; Middle Aged; Protein Biosynthesis; Prothrombin Time; Serum Albumin; Triglycerides | 1994 |
[Disorders of coagulation/fibrinolysis and bleeding tendency].
Topics: Antithrombin III; Blood Coagulation Disorders; Blood Coagulation Factors; Fibrinogen; Fibrinolysis; Hemorrhagic Disorders; Humans; Liver Cirrhosis; Plasminogen; Protein C | 1994 |
A new method of purification and sensitive bioassay of platelet-activating factor (PAF) in human whole blood.
Topics: Animals; Biological Assay; Epinephrine; Fibrinogen; Humans; Infections; Liver Cirrhosis; Platelet Activating Factor; Platelet Aggregation; Rabbits; Radioimmunoassay; Sensitivity and Specificity | 1994 |
Clinical studies on plasma protein C. Correlation with serum cholinesterase.
Topics: Adult; Aged; Aged, 80 and over; Cholestasis; Cholesterol; Cholinesterases; Critical Illness; Female; Fibrinogen; Humans; Hypertriglyceridemia; Liver Cirrhosis; Male; Middle Aged; Nephrotic Syndrome; Obesity; Protein C; Triglycerides | 1993 |
Disordered hemostasis in extrahepatic portal hypertension.
Topics: Adult; Blood Coagulation; Blood Coagulation Factors; Female; Fibrin; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Hypertension, Portal; Liver Cirrhosis; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Portal Vein; Thrombosis | 1993 |
Albumin but not fibrinogen synthesis correlates with galactose elimination capacity in patients with cirrhosis of the liver.
Topics: Adult; Aged; Aminopyrine; Blood Volume; Deuterium; Fibrinogen; Galactose; Gas Chromatography-Mass Spectrometry; Hepatitis B; Hepatitis C; Humans; Kinetics; Liver Cirrhosis; Male; Middle Aged; Phenylalanine; Radioisotope Dilution Technique; Serum Albumin | 1996 |
Influence of plasma composition on erythrocyte filtrability in alcoholic liver disease.
Topics: Blood Viscosity; Erythrocyte Deformability; Fibrinogen; Glycerides; Humans; Liver; Liver Cirrhosis; Liver Cirrhosis, Alcoholic | 1994 |
Lipoprotein (a) serum levels in patients with hepatocarcinoma.
Topics: Aged; Apolipoprotein B-100; Apolipoproteins B; Biomarkers, Tumor; Carcinoma, Hepatocellular; Female; Fibrinogen; Humans; Lipoprotein(a); Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Serum Albumin | 1997 |
Diagnostic value of serum copper, zinc and plasma fibrinogen in cirrhotic patients with and without hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Copper; Female; Fibrinogen; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Zinc | 1997 |
[Alterations of hemostasis in liver cirrhosis of the dog].
Topics: Animals; Blood Coagulation Factors; Dog Diseases; Dogs; Fibrin; Fibrinogen; Hemostasis; Humans; Liver Cirrhosis; Reference Values | 1998 |
Disseminated intravascular coagulation in liver cirrhosis: fact or fiction?
Topics: Adult; Aged; alpha-2-Antiplasmin; Antithrombin III; Disseminated Intravascular Coagulation; Female; Fibrinogen; Hemostasis; Humans; Liver Cirrhosis; Male; Middle Aged; Peptide Fragments; Peptide Hydrolases; Protein Precursors; Prothrombin; Prothrombin Time; Thrombelastography | 1999 |
Ascites fluid as a possible origin for hyperfibrinolysis in advanced liver disease.
Topics: Ascitic Fluid; Case-Control Studies; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Liver Cirrhosis; Male; Middle Aged; Plasminogen | 2000 |
Genetic and immunological characterization of fibrinogen inclusion bodies in patients with hepatic fibrinogen storage and liver disease.
Topics: Fibrinogen; Genetic Predisposition to Disease; Humans; Immunohistochemistry; Liver; Liver Cirrhosis; Liver Diseases | 2001 |
Platelet aggregation in portal cirrhosis.
Topics: Adenosine Diphosphate; Blood Cell Count; Blood Coagulation Tests; Blood Platelets; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Liver Cirrhosis; Platelet Aggregation; Serum Globulins; Thrombin | 1976 |
Immunologic measurement of antithrombin III-heparin cofactor and alpha2 macroglobulin in disseminated intravascular coagulation and hepatic failure coagulopathy.
Topics: Alpha-Globulins; Antithrombin III; Antithrombins; Aspirin; Blood Platelets; Chemical and Drug Induced Liver Injury; Disseminated Intravascular Coagulation; Female; Fetal Proteins; Fibrinogen; Humans; Immunoelectrophoresis; Liver Cirrhosis; Macroglobulins; Male | 1975 |
Coagulative and fibrinolytic properties of ascitic fluid associated with ovarian tumors.
Topics: Alpha-Globulins; Antithrombins; Ascitic Fluid; Coagulants; Factor V; Factor VIII; Female; Fibrinogen; Fibrinolytic Agents; Humans; Liver Cirrhosis; Ovarian Neoplasms; Plasminogen; Trypsin Inhibitors; Urokinase-Type Plasminogen Activator | 1975 |
Heparin cofactor activity measured with an amidolytic method.
Topics: Acute Disease; Alpha-Globulins; Antithrombin III; Antithrombins; Biological Assay; Blood Coagulation Tests; Disseminated Intravascular Coagulation; Fibrin; Fibrinogen; Heparin; Hexadimethrine Bromide; Humans; Liver Cirrhosis; Methods; Myocardial Infarction; Spectrophotometry; Thrombin | 1975 |
[Localization of HBsAg, immunoglobulins, fibrin and C3 in the liver by direct immunoflourescence].
Topics: Biopsy; Complement C3; Complement System Proteins; Cytoplasm; Epitopes; Fatty Liver; Fibrin; Fibrinogen; Fluorescent Antibody Technique; Hepatitis; Hepatitis B Antigens; Humans; Immunoglobulins; Liver; Liver Cirrhosis; Liver Diseases; Renal Dialysis | 1976 |
Schistosoma japonicum: anti-DNA responses, serum cryogelatification, and cryoprecipitation phenomena in infected rabbits.
Topics: alpha-Macroglobulins; Animals; Antibodies, Antinuclear; Antigen-Antibody Complex; Chemical Precipitation; Cold Temperature; Fibrinogen; Gels; Immunoglobulin G; Immunoglobulin M; Kidney Glomerulus; Liver Cirrhosis; Rabbits; Schistosoma; Schistosomiasis | 1977 |
[First clinical experiences with the small molecular synthetic thrombin inhibitor 4-amidinophenylpyruvic acid (APPA)].
Topics: Adult; Aged; Amidines; Angiomatosis; Blood Coagulation Tests; Disseminated Intravascular Coagulation; Female; Fibrinogen; Hepatitis; Humans; Liver Cirrhosis; Male; Middle Aged; Phenylpyruvic Acids; Polycythemia; Thrombin | 1977 |
Regulation of the thrombin time in cirrhosis.
Topics: Antithrombin III; Antithrombins; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Humans; Liver Cirrhosis; Plasminogen; Prothrombin Time; Thrombin; Thromboplastin; Thrombosis; Time Factors | 1976 |
Abnormal fibrin polymerization in liver disease.
Topics: Batroxobin; Blood Coagulation Tests; Carcinoma, Hepatocellular; Cholestasis; Chronic Disease; Fibrin; Fibrinogen; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Polymers; Thrombin; Time Factors | 1976 |
Coagulation abnormalities in liver disease.
Topics: Acute Disease; Antithrombins; Blood Coagulation Disorders; Blood Coagulation Tests; Carcinoma, Hepatocellular; Chronic Disease; Factor IX; Factor V; Factor VII; Factor VIII; Factor X; Factor XIII; Fibrinogen; Hepatitis; Humans; Jaundice, Chronic Idiopathic; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Liver Neoplasms; Neoplasm Metastasis; Prothrombin; Vitamin K | 1977 |
Reptilase time in cirrhosis and hepatocellular carcinoma.
Topics: Batroxobin; Carcinoma, Hepatocellular; Fibrinogen; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Liver Neoplasms; Peptide Hydrolases | 1977 |
Investigations on intravascular coagulation in liver disease: souble fibrin monomer complexes in liver cirrhosis.
Topics: Bacteriological Techniques; Blood Coagulation; Blood Coagulation Tests; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heparin; Humans; Injections, Subcutaneous; Liver Cirrhosis; Liver Diseases; Solubility; Staphylococcus | 1979 |
Relationship between endotoxaemia and protein concentration of ascites in cirrhotic patients.
Topics: Adult; Aged; Albumins; Ascitic Fluid; Blood Proteins; Endotoxins; Female; Fibrinogen; Globulins; Humans; Limulus Test; Liver Cirrhosis; Male; Middle Aged; Proteins; Specific Gravity | 1979 |
Fibrinopeptide A in human plasma--evaluation of a new radioimmunoassay technique on microliter--plates.
Topics: Animals; Dialysis; Fibrinogen; Fibrinopeptide A; Humans; Immune Sera; Liver Cirrhosis; Rabbits; Radioimmunoassay; Time Factors | 1979 |
A test method for the absence of thrombogenicity in factor IX complex.
Topics: Adult; Aged; Blood Coagulation; Factor IX; Fibrinogen; Hemophilia A; Hemostasis; Heparin; Humans; Liver Cirrhosis; Male; Middle Aged; Quality Control | 1979 |
[Biological significance of fibrinopeptide A elevation in the blood].
Topics: Breast Neoplasms; Bronchial Neoplasms; Fatty Liver; Female; Fibrinogen; Fibrinopeptide A; Half-Life; Humans; Liver Cirrhosis; Lymphoma, Non-Hodgkin; Pleural Effusion | 1977 |
Association of abnormal fibrin polymerisation with severe liver disease.
Topics: Aspartate Aminotransferases; Bilirubin; Blood Coagulation Disorders; Chronic Disease; Factor VII; Fibrin; Fibrinogen; Humans; Liver Cirrhosis; Liver Diseases; Prothrombin Time; Serum Albumin; Serum Globulins | 1977 |
Fibrinogen, fibrin degradation products and fibrinolysis in bilharzial (schistosomal) hepatic fibrosis.
Topics: Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Liver Cirrhosis; Schistosomiasis | 1977 |
[Fibrinogen and fibrin structure in patients with cirrhosis of the liver (author's transl)].
Topics: Blood Coagulation Disorders; Blood Platelets; Cell Count; Electrophoresis, Polyacrylamide Gel; Factor XIII; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Liver Cirrhosis; Sodium Dodecyl Sulfate | 1978 |
Quantitative abnormality of an Aalpha chain molecular weight form in the fibrinogen of cirrhotic patients.
Topics: Blood Coagulation Tests; Densitometry; Electrophoresis, Polyacrylamide Gel; Fibrin; Fibrinogen; Humans; Liver Cirrhosis; Male; Molecular Weight; Thrombin | 1978 |
Thrombin time prolongation in cirrhosis in relation to enhanced fibrinogen degradation.
Topics: Electrophoresis, Polyacrylamide Gel; Fibrinogen; Humans; Liver Cirrhosis; Molecular Weight; Prothrombin Time | 1977 |
[Value of thermal fractionation of lactate dehydrogenase and the protein composition of the blood in the differential diagnosis of the phases of acute pancreatitis].
Topics: Acute Disease; Blood Proteins; C-Reactive Protein; Clinical Enzyme Tests; Diagnosis, Differential; Fibrinogen; Hepatitis, Viral, Human; Humans; L-Lactate Dehydrogenase; Liver Cirrhosis; Pancreatitis | 1977 |
Impaired fibrin formation in advanced cirrhosis.
Topics: Adult; Aged; Blood Coagulation Tests; Fibrin; Fibrinogen; Fibrinolysis; Humans; Liver Cirrhosis; Middle Aged; Polymers; Thrombin; Time Factors | 1977 |
Dysfibrinogenemia associated with liver disease.
Topics: Alcoholism; Batroxobin; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Coagulation Tests; Chemical and Drug Induced Liver Injury; Fibrin; Fibrinogen; Humans; Liver Cirrhosis; Liver Diseases; Prothrombin Time; Thrombin | 1977 |
[Metabolism of fibrinogen in the cirrhotic patient. Dynamic study by isotope method].
Topics: Biological Clocks; Disseminated Intravascular Coagulation; Fibrinogen; Heparin; Humans; Iodine Radioisotopes; Liver Cirrhosis | 1976 |
Change of the molecular mass of fibrinogen in circulating blood, as an index of the hypercoagulable states.
Topics: Adult; Aged; Antigens; Blood Protein Disorders; Cold Temperature; Disseminated Intravascular Coagulation; Female; Fibrinogen; Humans; Leukemia; Liver Cirrhosis; Male; Thrombosis | 1976 |
[Hepatic cirrhosis and clearance of fibrinolysis activators].
Topics: Fibrinogen; Fibrinolysis; Humans; Liver; Liver Cirrhosis; Nicotinic Acids; Plasminogen Activators; Stimulation, Chemical | 1976 |
[Changes of blood-flow properties in patients with chronic liver disease (author's transl)].
Topics: Alanine Transaminase; Aspartate Aminotransferases; Blood Viscosity; Chronic Disease; Cortisone; Esophageal and Gastric Varices; Fibrinogen; Hepatitis; Humans; Hypertension, Portal; Immunoglobulin G; Immunosuppression Therapy; Liver Cirrhosis; Liver Diseases; Middle Aged | 1975 |
[Acanthocytosis of red blood cells. A case during hepatic cirrhosis with hemolysis and defibrination].
Topics: Anemia, Hemolytic; Blood Coagulation Disorders; Erythrocytes, Abnormal; Fibrinogen; Humans; Liver Cirrhosis; Male; Microscopy, Electron; Middle Aged; Polymers; Thrombin | 1975 |
Fibrinogen survival in cirrhosis: improvement by "low dose" heparin.
Topics: Disseminated Intravascular Coagulation; Fibrinogen; Half-Life; Heparin; Humans; Iodine Radioisotopes; Liver Cirrhosis; Time Factors | 1975 |
In vitro pleural fluid clottability and fibrinogen content.
Topics: Adult; Arthritis, Rheumatoid; Blood Coagulation Tests; Blood Proteins; Female; Fibrinogen; Fibrinolysis; Heart Failure; Hodgkin Disease; Humans; In Vitro Techniques; Liver Cirrhosis; Lung Neoplasms; Male; Middle Aged; Pleural Effusion; Pneumonia; Tuberculosis, Pulmonary | 1975 |
Proceedings: Abnormal fibrin monomer polymerization in liver disease.
Topics: Fibrin; Fibrinogen; Hemorrhage; Humans; Liver Cirrhosis; Liver Diseases | 1975 |
The extent of diffuse intravascular coagulation and fibrinolysis in patients with liver cirrhosis.
Topics: Adult; Aged; Antithrombin III; Blood Coagulation Factors; Cholinesterases; Female; Fibrinogen; Fibrinolysis; Humans; Liver Cirrhosis; Male; Middle Aged; Tissue Plasminogen Activator | 1992 |
Hemostasis activation during esophageal variceal sclerotherapy with thrombin in cirrhotics.
Topics: Adult; Aged; alpha-Macroglobulins; Antifibrinolytic Agents; Antithrombin III; Cefazolin; Esophageal and Gastric Varices; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Fibronectins; Hemostasis; Humans; Liver Cirrhosis; Male; Middle Aged; Peptide Hydrolases; Plasminogen Inactivators; Protein C; Sclerotherapy; Sodium Tetradecyl Sulfate; Thrombin; Tissue Plasminogen Activator | 1991 |
Sandwich enzyme immunoassay for serum integrins using monoclonal antibodies.
Topics: Animals; Antibodies, Monoclonal; Antibody Specificity; Biomarkers; Biomarkers, Tumor; Carcinoma, Hepatocellular; Enzyme-Linked Immunosorbent Assay; Fibrinogen; Glycoproteins; Hepatitis; Humans; Immunoblotting; Immunoenzyme Techniques; Integrins; Liver Cirrhosis; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Neoplasms; Platelet Membrane Glycoproteins; Receptors, Immunologic; Receptors, Vitronectin; Reference Values; Vitronectin | 1991 |
Correlations between plasma levels of fibrin(ogen) derivatives as quantified by different assays based on monoclonal antibodies.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Immunoenzyme Techniques; Liver Cirrhosis; Male; Middle Aged; Plasma; Thrombosis | 1991 |
Hemorrheological changes in chronic hepatitis and liver cirrhosis and their relations to the syndromes differentiated by traditional Chinese medicine.
Topics: Adult; Blood Viscosity; Chronic Disease; Female; Fibrinogen; Hepatitis, Viral, Human; Humans; Liver Cirrhosis; Male; Medicine, Chinese Traditional; Middle Aged; Regional Blood Flow; Tongue | 1990 |
Incidence and clinical significance of elevated fibrin(ogen) degradation product and/or D-dimer levels in liver cirrhosis patients.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Blood Coagulation Disorders; Disseminated Intravascular Coagulation; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Liver Cirrhosis; Male; Middle Aged; Platelet Count; Prothrombin | 1990 |
The use of laser-nephelometry in evaluating fibrinogenaemia in patients with hepatocarcinoma and cirrhosis.
Topics: Carcinoma, Hepatocellular; Fibrinogen; Humans; Kinetics; Lasers; Liver Cirrhosis; Liver Neoplasms; Nephelometry and Turbidimetry | 1985 |
Fibrinopeptide A and B beta 15-42 in liver cirrhosis.
Topics: Adult; alpha-2-Antiplasmin; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinopeptide A; Fibrinopeptide B; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Peptide Fragments | 1988 |
Use of microcrystalline collagen powder and fibrinogen tissue adhesive for hemostasis and prevention of rebleeding in patients with hepatocellular carcinoma associated with cirrhosis of the liver.
Topics: Aprotinin; Carcinoma, Hepatocellular; Collagen; Drug Combinations; Factor XIII; Fibrin Tissue Adhesive; Fibrinogen; Hemorrhage; Hemostasis, Surgical; Hepatectomy; Humans; Liver Cirrhosis; Liver Neoplasms; Powders; Thrombin; Tissue Adhesives | 1989 |
[Fibrin glue injection--a hemostatic technic after laparoscopic liver biopsy].
Topics: Adult; Aged; Aprotinin; Biopsy, Needle; Drug Combinations; Factor XIII; Female; Fibrin; Fibrin Tissue Adhesive; Fibrinogen; Hemostatic Techniques; Humans; Laparoscopy; Liver; Liver Cirrhosis; Male; Middle Aged; Thrombin; Tissue Adhesives | 1989 |
Endoplasmic storage disease of liver: characterization of intracytoplasmic hyaline inclusions.
Topics: Adult; Carcinoma, Hepatocellular; Complement C3; Complement C4; Endoplasmic Reticulum; Fibrinogen; Hepatitis B; Humans; Hyalin; Inclusion Bodies; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Male | 1989 |
[Anti-fibrinogen antibodies in chronic diseases of the liver].
Topics: Adult; Autoantibodies; Chronic Disease; Fatty Liver; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hepatitis; Humans; Liver Cirrhosis; Male; Middle Aged | 1989 |
Analysis of elevated fibrin(ogen) degradation product levels in patients with liver disease.
Topics: Agglutination; Alcoholism; Antibodies; Electrophoresis, Polyacrylamide Gel; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Hemosiderosis; Hepatitis; Humans; Immunosorbent Techniques; Liver Cirrhosis; Liver Diseases; Molecular Weight; Platelet Count; Polymers; Thrombin Time | 1986 |
Diagnostic and prognostic value of serum copper and plasma fibrinogen in hepatic carcinoma.
Topics: Adenoma, Bile Duct; Adolescent; Adult; Aged; Carcinoma, Hepatocellular; Copper; Diagnosis, Differential; Female; Fibrinogen; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged | 1985 |
A DIC-like picture on plasma and ascitic fluid of cirrhotic patients.
Topics: Aged; Ascites; Disseminated Intravascular Coagulation; Female; Fibrin; Fibrinogen; Fibrinopeptide A; Humans; Liver Cirrhosis; Male; Middle Aged; Partial Thromboplastin Time; Plasminogen; Prothrombin Time; Reference Values; Tissue Plasminogen Activator | 1988 |
[Evaluation of several parameters of coagulation in liver cirrhosis: disseminated intravascular coagulation or pseudo-disseminated intravascular coagulation?].
Topics: Adult; Aged; Blood Coagulation Disorders; Blood Coagulation Tests; Diagnosis, Differential; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Liver Cirrhosis; Male; Middle Aged; Partial Thromboplastin Time; Prothrombin Time | 1988 |
[Serum levels of fibrinogen degradation products in patients with hepatic cirrhosis].
Topics: Adult; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Liver Cirrhosis; Male; Middle Aged | 1987 |
Analysis of fibrinogen degradation product in severe liver disorders by immunoblotting.
Topics: Collodion; Disseminated Intravascular Coagulation; Electrophoresis, Polyacrylamide Gel; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Liver Cirrhosis; Liver Neoplasms; Molecular Weight | 1987 |
Study of the formation of fibrin clot in cirrhotic patients. An approach to study of acquired dysfibrinogenemia.
Topics: Afibrinogenemia; Blood Coagulation; Blood Coagulation Tests; Cross Reactions; Electrophoresis, Polyacrylamide Gel; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Liver Cirrhosis; Molecular Weight; Protein Conformation | 1987 |
Relationship between fibrinopeptide A and fibrinogen/fibrin fragment E in thromboembolism, DIC and various non-thromboembolic diseases.
Topics: Collagen Diseases; Disseminated Intravascular Coagulation; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinopeptide A; Humans; Liver Cirrhosis; Myocardial Infarction; Neoplasms; Thromboembolism | 1987 |
Turnover study of prothrombin, antithrombin III and fibrinogen in patients with liver cirrhosis.
Topics: Adult; Aged; Antithrombin III; Blood Coagulation Tests; Female; Fibrinogen; Humans; Liver Cirrhosis; Male; Middle Aged; Prothrombin | 1986 |
The effect of carbon tetrachloride-induced cirrhosis of the liver on fibrinogen-bound sialic acid and sialyltransferase activity in the rat.
Topics: Animals; Carbon Tetrachloride; Fibrinogen; Liver Cirrhosis; Male; N-Acetylneuraminic Acid; Protein Binding; Rats; Rats, Inbred Strains; Sialic Acids; Sialyltransferases; Transferases | 1986 |
Antibodies and intravascular clotting in liver cirrhosis.
Topics: Animals; Antibodies; Disseminated Intravascular Coagulation; Fibrinogen; Humans; Liver Cirrhosis | 1972 |
F.D.P.
Topics: Ascitic Fluid; Female; Fibrin; Fibrinogen; Humans; Liver Cirrhosis; Ovarian Neoplasms | 1972 |
[Fibrinolytic potential of the blood in liver damage].
Topics: Antithrombins; Blood Coagulation Tests; Caseins; Factor V; Factor VIII; Fibrinogen; Fibrinolysis; Hepatitis; Humans; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Mushroom Poisoning; Plasminogen; Prothrombin Time; Thromboplastin | 1974 |
[Disseminated intravascular coagulation in blastic leukemia and certain other disorders].
Topics: Acute Disease; Antithrombins; Blood Cell Count; Blood Coagulation Tests; Disseminated Intravascular Coagulation; Fibrin; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Leukemia; Leukemia, Monocytic, Acute; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Liver Cirrhosis; Lymphatic Diseases; Platelet Adhesiveness; Prothrombin Time; Retinal Detachment; Thrombin; Thrombophlebitis | 1974 |
The fibrinolytic enzyme system in acute and chronic liver injury.
Topics: Acute Disease; Adult; Aged; Alcoholism; alpha 1-Antitrypsin; Alpha-Globulins; Chronic Disease; Fatty Liver; Female; Fibrin; Fibrinogen; Fibrinolysis; Hepatitis; Humans; Liver Cirrhosis; Liver Cirrhosis, Biliary; Macroglobulins; Male; Middle Aged; Plasminogen | 1974 |
Investigations on plasma viscosity in patients with cirrhosis of the liver.
Topics: Blood Proteins; Blood Viscosity; Cholinesterases; Fibrinogen; gamma-Globulins; Humans; Liver Cirrhosis; Serum Albumin | 1974 |
Fibrinogen-transmitted hepatitis; a controlled study.
Topics: Abruptio Placentae; Afibrinogenemia; Aortic Aneurysm; Aspartate Aminotransferases; Embolism, Amniotic Fluid; Female; Fetal Death; Fibrinogen; gamma-Globulins; Hemorrhage; Hepatitis B; Humans; Liver Cirrhosis; Placenta Previa; Pregnancy; Thoracic Surgery; Thorax; Uterine Rupture | 1966 |
Circulating heparin-like anticoagulant following portacaval anastomosis.
Topics: Anticoagulants; Aprotinin; Blood Coagulation Tests; Fibrinogen; Heparin; Humans; Liver Cirrhosis; Male; Middle Aged; Portacaval Shunt, Surgical; Protamines | 1970 |
Disseminated intravascular coagulation during a fatal Mycoplasma pneumoniae infection.
Topics: Adult; Antibodies, Bacterial; Complement Fixation Tests; Complement System Proteins; Disseminated Intravascular Coagulation; Fibrinogen; Humans; Hypotension; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Liver Cirrhosis; Male; Mycoplasma; Mycoplasma Infections; Purpura; Respiratory Insufficiency; Shock, Hemorrhagic; Thrombocytopenia | 1974 |
Immunoelectrophoretic characterization of plasma fibrinogen derivatives in patients with pathological plasma proteolysis.
Topics: Acrylates; Agar; Aminocaproates; Animals; Blood Coagulation Disorders; Blood Coagulation Tests; Electrophoresis; Extracorporeal Circulation; Fibrinogen; Fibrinolysin; Fibrinolysis; Fibrinolytic Agents; Gels; Humans; Immune Sera; Immunoelectrophoresis; Liver Cirrhosis; Male; Molecular Weight; Nicotinic Acids; Plasma; Prostatic Neoplasms; Rabbits | 1967 |
Plasmatic and platelet anti-plasmins and anti-activators. 3. Results in normal people, in patients and in those with venous thrombosis.
Topics: Antifibrinolytic Agents; Blood Platelets; Blood Protein Electrophoresis; Enzymes; Fibrinogen; Fibrinolysin; Freezing; Humans; Liver Cirrhosis; Temperature; Thrombosis | 1969 |
Measurement of fibrinogen and fibrin degradation products in serum by staphylococcal clumping test.
Topics: Animals; Arthritis, Rheumatoid; Blood Coagulation Tests; Cats; Cattle; Chromatography, Gel; Electrophoresis; Fibrin; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Liver Cirrhosis; Methods; Prothrombin Time; Rabbits; Staphylococcus; Streptokinase; Thrombin; Thrombosis; Time Factors | 1970 |
A comparative study of four methods for detecting fibrinogen degradation products in patients with various diseases.
Topics: Adult; Agglutination Tests; Arthritis, Rheumatoid; Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Coagulation Tests; Contraceptives, Oral; Erythrocytes; False Negative Reactions; False Positive Reactions; Female; Fibrin; Fibrinogen; Fibrinolysin; Fibrinolysis; Hemagglutination Inhibition Tests; Hodgkin Disease; Humans; Immunoassay; Immunodiffusion; Kidney Diseases; Liver Cirrhosis; Lymphoma, Non-Hodgkin; Male; Methods; Middle Aged; Myocardial Infarction; Neoplasms; Plasminogen; Staphylococcus | 1970 |
The clinical significance of fibrinogen-fibrin-related antigen in serum.
Topics: Abruptio Placentae; Antigens; Blood Coagulation; Female; Fibrin; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Liver Cirrhosis; Neoplasms; Pregnancy | 1971 |
Fibrinolytic activity in hepatic cirrhosis.
Topics: Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Immunodiffusion; Immunoelectrophoresis; Liver Cirrhosis; Plasminogen | 1972 |
[Coagulation disorders after reinjection of concentrated ascitic fluid. Preliminary study].
Topics: Aminocaproates; Ascitic Fluid; Blood Coagulation Disorders; Blood Coagulation Tests; Disseminated Intravascular Coagulation; Fibrinogen; Fibrinolysin; Hemorrhage; Humans; Infusions, Parenteral; Liver Cirrhosis; Plasminogen | 1973 |
[Changes in the carbohydrate composition of fibrinogen in cases of acquired dysfibrinogenemia].
Topics: Blood Coagulation Disorders; Blood Protein Disorders; Carcinoma, Hepatocellular; Chemical Phenomena; Chemistry; Fibrinogen; Hexosamines; Hexoses; Humans; Jaundice; Liver Cirrhosis; Liver Neoplasms; Neuraminic Acids | 1970 |
Plasma fibrinogen in health and disease. Its application in the differential diagnosis of an enlarged and irregular liver.
Topics: Adult; Aged; Alcoholism; Carcinoma, Hepatocellular; Fatty Liver; Fibrinogen; Hepatomegaly; Humans; Intestinal Neoplasms; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis | 1972 |
[Acquired dysfibrinogenemia and hepatic disorders. Apropos of 30 cases].
Topics: Adenocarcinoma; Adult; Aged; Alcoholism; Blood Coagulation Disorders; Blood Coagulation Tests; Female; Fibrinogen; Giant Cell Arteritis; Hepatitis; Hepatitis A; Humans; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Male; Middle Aged; Prognosis | 1973 |
Fibrinogen in liver disease.
Topics: Acetaminophen; Chemical and Drug Induced Liver Injury; Cholangitis; Cholestasis; Contusions; Endotoxins; Fibrinogen; Humans; Iodine Radioisotopes; Liver; Liver Cirrhosis; Liver Diseases; Pseudomonas Infections; Sepsis; Toxemia | 1974 |
Regulation of fibrinogen synthesis in portal hypertension.
Topics: Animals; Blood Coagulation Factors; Blood Volume; Body Weight; Carbon Radioisotopes; Female; Fibrinogen; Guinea Pigs; Hypertension, Portal; Leucine; Ligation; Liver; Liver Cirrhosis; Male; Organ Size; Portacaval Shunt, Surgical; Portal Vein | 1974 |
[Coagulation and fibrinolytic systems of the blood in patients with cirrhosis and primary cancer of the liver].
Topics: Blood Coagulation; Fibrinogen; Fibrinolysis; Humans; Liver Cirrhosis; Liver Neoplasms | 1974 |
Abnormalities of platelet aggregation in patients with alcoholic cirrhosis.
Topics: Alcoholism; Blood Coagulation Tests; Fibrinogen; Fibrinolysis; Humans; Liver Cirrhosis; Platelet Adhesiveness | 1972 |
Coagulation factors as indicators of protein synthesis in chronic liver disease.
Topics: Blood Cell Count; Blood Coagulation Factors; Blood Coagulation Tests; Blood Platelets; Chronic Disease; Female; Fibrinogen; Hepatitis; Humans; Indicators and Reagents; Liver Cirrhosis; Liver Cirrhosis, Biliary; Male; Methods; Serum Albumin | 1973 |
Heparin therapy in the case of acute liver cirrhosis.
Topics: Acute Disease; Alanine Transaminase; Aspartate Aminotransferases; Bilirubin; Blood Cell Count; Blood Coagulation Factors; Blood Coagulation Tests; Blood Platelets; Disseminated Intravascular Coagulation; Factor IX; Factor V; Factor VII; Factor X; Factor XIII; Female; Fibrinogen; Heparin; Humans; Liver Cirrhosis; Male; Methods; Prothrombin; Serum Globulins; Solubility; Vitamin K 1 | 1973 |
The diagnostic value of coagulation studies in chronic liver disease.
Topics: Blood Coagulation Tests; Chronic Disease; Factor V; Fibrinogen; Hepatitis; Humans; Indicators and Reagents; Liver Cirrhosis; Liver Diseases; Methods; Prothrombin Time | 1973 |
[On the diagnosis of imminent bleeding from esophageal varices (author's transl)].
Topics: Ammonia; Blood; Blood Coagulation Disorders; Blood Viscosity; Disseminated Intravascular Coagulation; Esophageal and Gastric Varices; Ferritins; Fibrinogen; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Liver Cirrhosis | 1973 |
[Study of the kinetics of platelets and fibrinogen by radioisotopic labelling in splenomegalic cirrhosis with thrombopenia].
Topics: Blood Platelets; Chromium Isotopes; Disseminated Intravascular Coagulation; Female; Fibrinogen; Humans; Iodine Isotopes; Kinetics; Liver Cirrhosis; Male; Radionuclide Imaging; Spleen; Splenomegaly; Thrombocytopenia | 1972 |
[Case of hypofibrinogenemia with disorders of fibrin polymerization during hepatic cirrhosis].
Topics: Afibrinogenemia; Fibrin; Fibrinogen; Humans; Liver Cirrhosis; Male; Middle Aged; Polymers | 1974 |
[Plasma viscosity, immunoglobulins and fibrinogen in cirrhosis of the liver].
Topics: Blood; Blood Proteins; Blood Viscosity; Collateral Circulation; Fibrinogen; Glutamate Dehydrogenase; Hepatitis; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Immunoglobulins; Liver Cirrhosis; Serum Albumin | 1972 |
[Biochemical, physiopathological and clinical aspects of platelet adhesiveness].
Topics: Arteriosclerosis; Blood Coagulation; Blood Coagulation Disorders; Blood Platelet Disorders; Collagen; Diabetes Mellitus; Epinephrine; Fatty Acids; Fibrinogen; Humans; Liver Cirrhosis; Norepinephrine; Platelet Adhesiveness; Sarcoma; Serotonin; Thrombin; Trypsin; Uremia | 1972 |
Disseminated intravascular coagulation.
Topics: Blood Cell Count; Blood Platelets; Chronic Disease; Disseminated Intravascular Coagulation; Female; Fibrin; Fibrinogen; Fibrinolysis; Heparin; Humans; Liver Cirrhosis; Pregnancy; Pregnancy Complications, Hematologic; Prothrombin Time; Thrombin; Thromboplastin | 1973 |
[Measurement of fibrinogen degradation products: its usefulness in consumption coagulopathies].
Topics: Agglutination Tests; Blood Coagulation Disorders; Disseminated Intravascular Coagulation; Fibrin; Fibrinogen; Hemagglutination Inhibition Tests; Humans; Liver Cirrhosis; Neoplasms; Staphylococcus | 1973 |
The clinical significance of the plasminogen level.
Topics: Adolescent; Adult; Afibrinogenemia; Blood Coagulation Tests; Contraceptives, Oral; Diagnosis, Differential; Disseminated Intravascular Coagulation; Female; Fibrinogen; Hemorrhagic Disorders; Humans; Infections; Liver Cirrhosis; Male; Menstruation; Middle Aged; Myocardial Infarction; Neoplasms; Plasminogen; Sex Factors; Surgical Procedures, Operative; Thrombosis; Wounds and Injuries | 1973 |
[Plasma viscosity and portal hypertension in liver cirrhosis (author's transl)].
Topics: Adult; Aged; Blood Coagulation; Blood Proteins; Blood Viscosity; Esophageal and Gastric Varices; Female; Fibrinogen; Fibrinolysis; Humans; Hypertension, Portal; Immunoglobulin G; Liver Cirrhosis; Male; Microcirculation; Middle Aged | 1973 |
Antihaemophilic factor A (F VIII) and serum fibrin-fibrinogen degradation products in hepatic cirrhosis.
Topics: Blood Coagulation Disorders; Blood Coagulation Factors; Disseminated Intravascular Coagulation; Factor VIII; Female; Fibrin; Fibrinogen; Fibrinolysis; Hemagglutination Inhibition Tests; Humans; Liver Cirrhosis; Male; Plasminogen; Thromboplastin | 1973 |
Complement and liver cell function in 53 patients with liver disease.
Topics: Adult; Aged; Child; Cholesterol; Complement System Proteins; Factor V; Factor VII; Factor X; Female; Fibrinogen; Glomerulonephritis; Hepatitis; Humans; Immunologic Deficiency Syndromes; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Male; Middle Aged; Prothrombin; Prothrombin Time; Purpura, Thrombocytopenic; Serum Albumin | 1973 |
[Physiopathology of the process of fibrin stabilization].
Topics: Abortion, Septic; Anuria; Arteriosclerosis; Blood Coagulation Disorders; Disseminated Intravascular Coagulation; Factor XIII; Female; Fibrinogen; Fibrinolysis; Humans; Hyperlipidemias; Leukemia; Liver Cirrhosis; Pregnancy | 1973 |
[Decomposition products of fibrin(ogen) and collateral circulation in liver cirrhosis].
Topics: Blood Protein Electrophoresis; Collateral Circulation; Fibrin; Fibrinogen; Humans; Immunoelectrophoresis; Immunoglobulin G; Liver Circulation; Liver Cirrhosis; Microcirculation; Thrombocytopenia | 1973 |
[Chronic fibrinolysis in alcoholic cirrhosis].
Topics: Alcoholism; Blood Cell Count; Blood Platelets; Chronic Disease; Fibrinogen; Fibrinolysis; Heparin; Humans; Liver Cirrhosis; Male | 1974 |
Fibrinolytic activity and haemagglutination inhibition immunoassays.
Topics: Adult; Aged; Biguanides; Clofibrate; Coronary Disease; Ethylestrenol; Female; Fibrin; Fibrinogen; Fibrinolysis; Hemagglutination Inhibition Tests; Hemostasis; Humans; Immunoassay; Immunodiffusion; Immunoelectrophoresis; Liver Cirrhosis; Male; Metformin; Middle Aged; Neoplasm Metastasis; Nicotinic Acids; Physical Exertion; Plasminogen; Prostatic Neoplasms; Stimulation, Chemical; Time Factors; Tolazamide | 1970 |
[Fibrinogen and fibrin degradation products (FDP) in hepatic cirrhosis].
Topics: Blood Coagulation Disorders; Fibrin; Fibrinogen; Humans; Liver Cirrhosis | 1972 |
Platelet and fibrinogen kinetics with ( 75 Se)selenomethionine in thrombocytopenic states. II.
Topics: Adrenal Cortex Hormones; Blood Coagulation; Blood Platelets; Female; Fibrinogen; Humans; Kinetics; Leukemia; Liver Cirrhosis; Lymphoma; Methionine; Selenium; Splenectomy; Thrombocytosis | 1972 |
Specific determinations of prothrombin for evaluation of liver function.
Topics: Adolescent; Adult; Age Factors; Aged; Alanine Transaminase; Alcoholic Intoxication; Antithrombins; Blood Cell Count; Blood Platelets; Blood Protein Electrophoresis; Blood Proteins; Factor IX; Factor V; Female; Fibrinogen; Hepatitis; Humans; Liver Cirrhosis; Liver Function Tests; Male; Prothrombin; Sex Factors | 1972 |
Plasma protein pattern in cirrhosis of the liver.
Topics: Adult; Aged; Alcoholism; Blood Proteins; C-Reactive Protein; Female; Fibrinogen; Glycoproteins; Haptoglobins; Humans; Immunoelectrophoresis; Liver Cirrhosis; Male; Middle Aged; Mucoproteins; Trypsin Inhibitors | 1972 |
[Blood coagulation disorder in liver cirrhosis. Clinical and clinicochemical observations].
Topics: Adult; Aged; Ammonia; Blood Cell Count; Blood Coagulation Tests; Disseminated Intravascular Coagulation; Esophageal and Gastric Varices; Female; Fibrinogen; Humans; Liver Cirrhosis; Male; Middle Aged; Portography; Prothrombin Time; Radionuclide Imaging; Thrombelastography; Thrombocytopenia | 1972 |
[Blood coagulation changes in splenic diseases].
Topics: Animals; Blood Coagulation; Blood Coagulation Disorders; Dogs; Fibrinogen; Fibrinolysis; Heparin; Humans; Leukocyte Count; Liver Cirrhosis; Prothrombin; Spleen; Splenectomy; Splenic Diseases; Splenic Infarction; Splenic Rupture; Splenic Vein; Splenomegaly; Thrombosis; Time Factors; Tissue Extracts | 1972 |
Detection of fibrinogen-fibrin degradation products by counterelectrophoresis.
Topics: Blood Coagulation Tests; Contraceptives, Oral; Female; Fibrin; Fibrinogen; Humans; Immunoelectrophoresis; Liver Cirrhosis; Methods; Neoplasms; Postoperative Complications; Precipitin Tests; Sepsis; Thrombin | 1972 |
Metabolism of fibrinogen in cirrhosis of the liver.
Topics: Adult; Aged; Blood Coagulation Disorders; Computers; Disseminated Intravascular Coagulation; Female; Fibrinogen; Fibrinolysis; Half-Life; Heparin; Humans; Immunoelectrophoresis; Iodine Isotopes; Liver Cirrhosis; Male; Middle Aged; Plasma Volume; Statistics as Topic | 1971 |
[Half life determination of 131 I marked fibrinogen on patients with liver cirrhosis and esophageal varices].
Topics: Esophageal and Gastric Varices; Fibrinogen; Half-Life; Humans; Iodine Radioisotopes; Liver Cirrhosis; Time | 1971 |
The fibrinolytic enzyme system in hepatic cirrhosis and malignant metastases.
Topics: Adult; Aged; Female; Fibrinogen; Fibrinolysis; Humans; Liver; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Necrosis; Neoplasm Metastasis; Plasminogen | 1971 |
Metabolism of fibrinogen in cirrhosis of the liver.
Topics: Adult; Blood Coagulation Disorders; Computers; Disseminated Intravascular Coagulation; Female; Fibrinogen; Fibrinolysis; Half-Life; Heparin; Humans; Immunoelectrophoresis; Iodine Isotopes; Liver Cirrhosis; Male; Middle Aged; Plasma Volume; Statistics as Topic | 1971 |
[Hemagglutination inhibition (Merskey's test) in consumption coagulopathies. Apropos of 101 patients].
Topics: Abortion, Septic; Asparaginase; Blood Coagulation Disorders; Disseminated Intravascular Coagulation; Extracorporeal Circulation; Female; Fibrinogen; Fibrinolysis; Hemagglutination Inhibition Tests; Humans; Leukemia, Myeloid, Acute; Liver Cirrhosis; Pregnancy; Streptokinase | 1971 |
[Some indices of the blood coagulation system in patients with liver cirrhosis before and after surgery].
Topics: Adult; Blood Coagulation Disorders; Blood Coagulation Tests; Fibrinogen; Gastrointestinal Hemorrhage; Hepatitis A; Humans; Liver Cirrhosis; Male; Splenomegaly | 1966 |
Proteinase inhibitors in portasystemic shunts.
Topics: Aminocaproates; Aprotinin; Blood Coagulation Disorders; Blood Transfusion; Fibrinogen; Fibrinolysis; Hemorrhagic Disorders; Humans; Liver Cirrhosis; Portal System; Postoperative Complications; Time Factors | 1968 |
Eight years of experience with massive blood transfusions.
Topics: Abdominal Injuries; Adolescent; Adult; Age Factors; Aneurysm; Blood Coagulation Disorders; Blood Group Incompatibility; Blood Platelet Disorders; Blood Transfusion; Child; Coombs Test; Factor V Deficiency; Factor VIII; Fibrinogen; Gastrointestinal Hemorrhage; Hemorrhage; Homeostasis; Humans; Infections; Liver Cirrhosis; Middle Aged; Neoplasms; Pancreatitis; Prothrombin Time; Retrospective Studies; Rupture; Shock; Vascular Diseases; Wounds and Injuries | 1971 |
Fibrinolysis at rest and after exercise in hepatic cirrhosis.
Topics: Adult; Aged; Female; Fibrin; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Humans; Liver Cirrhosis; Male; Middle Aged; Physical Exertion; Plasminogen; Serum Globulins | 1969 |
Plasma fibrin-stabilizing factor: acquired deficiency in various disorders.
Topics: Acute Disease; Adult; Aged; Anemia, Macrocytic; Anemia, Sickle Cell; Blood Coagulation Disorders; Blood Coagulation Tests; Coronary Disease; Cysteine; Factor XIII; Fibrinogen; Hepatitis; Hot Temperature; Humans; Leukemia; Liver Cirrhosis; Liver Neoplasms; Lupus Erythematosus, Systemic; Lymphoma; Methods; Middle Aged; Myeloproliferative Disorders; Neoplasm Metastasis; Prothrombin Time; Uremia | 1969 |
Pharmacological enhancement and short-term stimulation of blood fibrinolytic activity.
Topics: Adolescent; Adult; Aged; Aminocaproates; Anticholesteremic Agents; Arteriosclerosis; Arthritis, Rheumatoid; Asthma; Clofibrate; Diabetes Mellitus; Female; Fibrinogen; Fibrinolysis; Humans; Hypoglycemic Agents; Immunoassay; Intermittent Claudication; Kidney Failure, Chronic; Liver Cirrhosis; Lung Neoplasms; Male; Metformin; Middle Aged; Neoplasm Metastasis; Nicotinic Acids; Phlebitis; Physical Exertion; Plasminogen; Primary Myelofibrosis; Propionates; Pulmonary Heart Disease; Testosterone; Tolazamide; Urea | 1969 |
Augmentation of albumin but not fibrinogen synthesis by corticosteroids in patients with hepatocellular disease.
Topics: Adult; Albumins; Body Weight; Carbon Isotopes; Chronic Disease; Female; Fibrinogen; Hepatitis; Humans; Liver Cirrhosis; Male; Middle Aged; Plasma Volume; Prednisolone; Serum Albumin | 1970 |
Simultaneous fibrinogen and platelet survival with (75Se)selenomethionine in man. Studies in diseases with normal coagulation and in hepatocellular disease with abnormal coagulation.
Topics: Blood Cell Count; Blood Coagulation Disorders; Blood Platelets; Fibrinogen; Fibrinolysis; Hemolysis; Humans; Liver Cirrhosis; Liver Diseases; Prothrombin Time; Radioisotopes; Selenium | 1970 |
Mechanisms of acquired defects of the stabilization of fibrin.
Topics: Adsorption; Aluminum Silicates; Blood Coagulation Disorders; Dialysis; Factor XIII; Fibrinogen; Hot Temperature; Humans; Kidney Failure, Chronic; Liver Cirrhosis; Liver Diseases; Necrosis | 1971 |
Fibrinogen degradation products.
Topics: Cerebrovascular Disorders; Disseminated Intravascular Coagulation; Fibrinogen; Hemagglutination Inhibition Tests; Humans; Liver Cirrhosis; Myocardial Infarction; Neoplasms; Pulmonary Embolism; Vascular Diseases | 1971 |
[On the problem of atherosclerosis in liver cirrhosis].
Topics: Adult; Aged; Arteriosclerosis; Blood Coagulation Tests; Cholesterol; Coronary Disease; Fibrinogen; Fibrinolysis; Heparin; Humans; Lipid Metabolism; Liver Cirrhosis; Middle Aged; Phospholipids; Thrombelastography | 1967 |
[Coagulation studies in liver diseases of children].
Topics: Adolescent; Alkaline Phosphatase; Bile Ducts; Bilirubin; Blood Coagulation Tests; Child; Child, Preschool; Factor V; Factor VII; Factor X; Fibrinogen; Gallbladder Diseases; Hepatitis A; Hepatolenticular Degeneration; Humans; Infant; Liver Cirrhosis; Liver Diseases; Prothrombin Time; Transaminases | 1968 |
Urokinase therapy in pulmonary thromboembolism.
Topics: Adult; Aged; Angiography; Arteriosclerosis; Blood Coagulation Tests; Brain Diseases; Breast Neoplasms; Fibrinogen; Fibrinolytic Agents; Humans; Liver Cirrhosis; Middle Aged; Obesity; Phlebitis; Plasminogen; Prothrombin Time; Pulmonary Embolism; Radionuclide Imaging; Schizophrenia; Thromboembolism | 1968 |
Studies on fibrinolysis in patients with Banti's syndrome.
Topics: Adolescent; Adult; Female; Fibrinogen; Fibrinolysis; Humans; Hypersplenism; Liver; Liver Cirrhosis; Male; Middle Aged; Plasminogen; Spleen; Splenectomy | 1968 |
[Paper and agar electrophoresis results of pathologic plasma proteins with specific reference to fibrinogens].
Topics: Blood Protein Disorders; Blood Protein Electrophoresis; Fibrinogen; Hepatitis A; Humans; Immunoelectrophoresis; Liver Cirrhosis; Neoplasms | 1968 |
[The state of the blood coagulation system in children with cirrhosis of the liver].
Topics: Adolescent; Blood Coagulation; Child; Child, Preschool; Fatty Liver; Fibrinogen; Humans; Infant; Liver Cirrhosis; Prothrombin | 1968 |
Plasma fibrin stabilising factor (F.S.F.) activity in normal subjects and patients with chronic liver disease.
Topics: Acetates; Adolescent; Adult; Age Factors; Aged; Blood Coagulation Factors; Calcium; Factor XIII; Female; Fibrinogen; Hepatitis; Humans; Liver Cirrhosis; Liver Cirrhosis, Biliary; Liver Diseases; Male; Middle Aged; Thrombin; Time Factors | 1969 |
Coagulation factors in human lymph and plasma.
Topics: Anticoagulants; Antithrombins; Blood Coagulation Factors; Factor V; Factor VIII; Fibrinogen; Humans; Liver Cirrhosis; Lung Neoplasms; Lymph; Pancreatitis; Prothrombin; Thoracic Duct | 1965 |
[Severe fibrinolytic hemorrhage after bilateral ligation of the external iliac vein].
Topics: Blood Coagulation Disorders; Blood Transfusion; Caproates; Fibrinogen; Fibrinolysis; Hemorrhage; Heparin; Humans; Iliac Vein; Liver Cirrhosis; Mitral Valve Insufficiency | 1965 |
[Haptoglobin in hepatic cirrhosis].
Topics: Blood Protein Electrophoresis; Fibrinogen; Haptoglobins; Humans; Liver Cirrhosis; Prothrombin Time | 1964 |
Evaluation of fibrinolysis in hepatic cirrhosis. Relation of serial thrombin time and euglobulin lysis time.
Topics: Aminocaproates; Blood Coagulation Tests; Fibrinogen; Fibrinolysis; Hemorrhagic Disorders; Humans; In Vitro Techniques; Injections, Intravenous; Liver Cirrhosis; Nicotinic Acids; Statistics as Topic | 1966 |
Age and disease-related alterations in fibrinogen-euglobulin (fibrinolytic) behavior.
Topics: Adult; Aged; Aging; Blood; Diabetes Mellitus; Female; Fibrinogen; Fibrinolysis; Humans; Liver Cirrhosis; Male; Middle Aged; Serum Globulins | 1966 |
Turnover of 131-I-labelled fibrinogen in man. Studies in normal subjects, in congenital coagulation factor deficiency states, in liver cirrhosis, in polycythemia vera and in epidermolysis bullosa.
Topics: Adolescent; Adult; Blood Coagulation Disorders; Epidermolysis Bullosa; Female; Fibrinogen; Humans; In Vitro Techniques; Iodine Isotopes; Liver Cirrhosis; Male; Middle Aged; Polycythemia Vera | 1966 |